UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended:September 30, 2018March 31, 2019

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File No. 000-33383

 

JERRICK MEDIA HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 87-0645394
(State or other jurisdiction
of incorporation)
 (IRS Employer
Identification No.)

 

2050 Center Avenue Suite 640

Fort Lee, New Jersey 07024

(Address of principal executive offices)

 

(201) 258-3770

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whetherwhether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
NoneNoneNone

 

As of November 19, 2018,May 14, 2019, there were 119,965,073151,157,777 shares outstanding of the registrant’s common stock.

 

 

 

 

 

 

TABLE OF CONTENTS

 

 PART I – FINANCIAL INFORMATION 
   
Item 1.Condensed Consolidated Financial Statements1
   
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations3626
   
Item 3.Quantitative and Qualitative Disclosures About Market Risk4228
   
Item 4.Controls and Procedures4228
   
 PART II – OTHER INFORMATION 
   
Item 1.Legal Proceedings4329
  
Item 1A.Risk Factors4329
   
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds4329
   
Item 3.Defaults Upon Senior Securities4329
   
Item 4.Mine Safety Disclosures4329
   
Item 5.Other Information4329
  
Item 6.Exhibits4430
   
Signatures4531

   

i

 

  

PART I – FINANCIAL INFORMATION

 

Item 1.Condensed Consolidated Financial Statements

 

Jerrick Media Holdings, Inc.

 

September 30,March 31, 2019 and 2018 and 2017

 

Index to the Condensed Consolidated Financial Statements

 

Contents Page(s)
   
Condensed Consolidated Balance Sheets as of September 30, 2018March 31, 2019 (unaudited) and December 31, 20172018 2
   
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30,March 31, 2019 and 2018 and 2017 (unaudited) 3

Condensed Consolidated Statement of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2018

4
Condensed Consolidated Statement of Changes in Stockholders’ Equity for the Three Months Ended March 31, 20195
   
Condensed Consolidated Statements of Cash Flows for the NineThree Months Ended September 30,March 31, 2019 and 2018 and 2017 (unaudited) 46
   
Notes to the Condensed Consolidated Financial Statements (unaudited) 57

1


Jerrick Media Holdings, Inc.

Condensed Consolidated Balance SheetSheets

  March 31, 2019  December 31, 2018 
Assets (Unaudited)    
       
Current Assets        
Cash $262,707  $- 
Accounts receivable  7,566   6,500 
 Total Current Assets  270,273   6,500 
         
Property and equipment, net  19,633   42,443 
         
Deferred offering costs  -   143,146 
         
Security deposit  16,836   16,836 
         
Operating lease right of use asset  277,232   - 
         
Total Assets $583,974  $208,925 
         
Liabilities and Stockholders’ Deficit        
         
Current Liabilities        
Cash overdraft $-  $33,573 
Accounts payable and accrued liabilities  1,240,004   1,246,207 
Demand loan  300,000   - 
Convertible Notes, net of debt discount and issuance costs  761,480   - 
Current portion of operating lease payable  77,928   - 
Note payable - related party, net of debt discount  1,489,716   1,223,073 
Note payable, net of debt discount and issuance costs  -   49,926 
Deferred revenue  -   9,005 
Deferred rent  -   7,800 
         
 Total Current Liabilities  3,869,128   2,569,584 
         
Non-current Liabilities:        

Operating lease payable, long term

  191,120   6,150 
Convertible Notes - related party, net of debt discount  355   314 
Convertible Notes, net of debt discount and issuance costs  75,000   123,481 
         
 Total Non-current Liabilities  266,475   129,945 
         
Total Liabilities  4,135,603   2,699,529 
         
Commitments and contingencies        
         
Stockholders’ Deficit        
Common stock par value $0.001: 300,000,000 shares authorized; 134,606,122 and 129,506,802 issued and outstanding as of March 31, 2019 and December 31, 2018 respectively  134,606   129,507 
Additional paid in capital  34,964,052   33,977,295 
Accumulated deficit  (38,429,506)  (36,545,065)
Less: Treasury stock, 2,233,334 and 553,334 shares, respectively  (220,781)  (52,341)
   (3,551,629)  (2,490,604)
         
Total Liabilities and Stockholders’ Deficit $583,974  $208,925 

  

  September 30,
2018
  December 31,
2017
 
  (Unaudited)  (revised) 
       
Assets      
       
Current Assets      
Cash $186,278  $111,051 
Prepaid expenses  39,644   - 
Accounts receivable  6,957   1,325 
Total Current Assets  232,879   112,376 
         
Property and equipment, net  48,031   48,056 
         
Security deposit  16,836   17,000 
         
Total Assets $297,746  $177,432 
         
Liabilities and Stockholders’ Deficit        
         
Current Liabilities        
Accounts payable and accrued liabilities $1,121,056  $1,462,106 
Demand loan  -   10,366 
Convertible Notes, net of debt discount and issuance costs  40,401   96,500 
Current portion of capital lease payable  4,732   4,732 
Note payable - related party, net of debt discount  1,112,295   1,249,000 
Note payable, net of debt discount and issuance costs  105,128   689,500 
Line of credit - related party  -   130,000 
Line of credit  -   44,996 
Deferred rent  11,829   - 
Investor Deposit  208,428   - 
         
Total Current Liabilities  2,603,869   3,687,200 
         
Non-current Liabilities:        
Convertible Notes - related party, net of debt discount  314   1,345,246 
Convertible Notes, net of debt discount and issuance costs  186,103   2,512,293 
         
Total Non-current Liabilities  186,417   3,857,539 
         
Total Liabilities  2,790,286   7,544,739 
         
Commitments and contingencies        
         
Stockholders’ Deficit        
Series A Preferred stock, $0.001 par value, 31,581 and 33,314 shares issued and outstanding, respectively  -   31 
Series B Preferred stock, $0.001 par value, 8,063 and 8,063 shares issued and outstanding, respectively  -   8 
Series D Preferred stock, $0.001 par value, 0 and 0 shares issued and outstanding, respectively  -   - 
Common stock par value $0.001: 300,000,000 shares authorized; 40,524,432 and 33,894,582 issued and outstanding as of June 30, 2018 and December 31,2017 respectively  119,321   39,521 
Additional paid in capital  31,990,831   14,387,247 
Accumulated deficit  (34,583,684)  (21,775,107)
Less: Treasury stock, 220,000 and 220,000 shares, respectively  (19,007)  (19,007)
   (2,492,539)  (7,367,307)
         
Total Liabilities and Stockholders’ Deficit $297,747  $177,432 

The accompanying notes are an integral part of these condensed consolidated financial statements.


2

Jerrick Media Holdings, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

  For the Three Months Ended  For the Three Months Ended  For the Nine Months Ended  For the Nine Months Ended 
  September 30,
2018
  September 30,
2017
  September 30,
2018
  September 30,
2017
 
     (revised)     (revised) 
Net revenue $25,119  $11,244  $65,391  $105,345 
                 
Operating expenses                
Compensation  446,094   280,674   1,548,923   1,536,082 
Consulting fees  73,603   725,486   520,206   903,056 
General and administrative  388,010   412,226   1,768,130   1,048,979 
                 
Total operating expenses  907,707   1,418,386   3,837,259   3,488,117 
                 
Loss from operations  (882,588)  (1,407,142)  (3,771,868)  (3,382,772)
                 
Other income (expenses)                
Interest expense  (279,163)  (228,120)  (888,359)  (372,825)
Accretion of debt discount and issuance cost  (1,449,656)  (800,614)  (2,039,589)  (1,525,514)
Change In derivative liability  -   (64,346)  -   (64,346)
Settlement of vendor liabilities  1,011   -   2,886   (110,674)
Loss on extinguishment of debt  (2,938,719)  (923,822)  (3,370,505)  (923,822)
(Loss) gain on settlement of debt  1,823   2,079   15,275   2,079 
                 
Other income (expenses)  (4,664,704)  (2,014,823)  (6,280,292)  (2,995,102)
                 
Loss before income tax provision  (5,547,292)  (3,421,965)  (10,052,160)  (6,377,874)
                 
Income tax provision  -   -   -   - 
                 
Net loss $(5,547,292) $(3,421,965) $(10,052,160) $(6,377,874)
                 
Deemed dividend $45,367  $74,014  $174,232  $203,365 
Inducement to convert convertible preferred stock  2,016,634   -   2,016,634   - 
                 
Net loss attributable to common shareholders  (7,609,293)  (3,495,979)  (12,243,026)  (6,581,239)
                 
Per-share data                
Basic and diluted loss per share  (0.11)  (0.09)  (0.25)  (0.17)
                 
Weighted average number of common shares outstanding  66,608,083   39,469,670   49,046,551   38,343,241 

  For the Three Months Ended  For the Three Months Ended 
  March 31, 2019  March 31, 2018 
       
       
Net revenue $34,334  $16,249 
         
Gross margin  34,334   16,249 
         
Operating expenses        
Compensation  726,574   651,788 
Consulting fees  206,377   95,799 
Research and development  341,339   187,577 
General and administrative  465,038   404,662 
         
Total operating expenses  1,739,328   1,339,826 
         
Loss from operations  (1,704,994)  (1,323,577)
         
Other income (expenses)        
Interest expense  (54,569)  (268,125)
Accretion of debt discount and issuance cost  (47,364)  (174,888)
Settlement of vendor liabilities  -   1,875 
Loss on extinguishment of debt  (77,514)  (342,367)
Gain (loss) on settlement of debt  -   13,452 
         
Other income (expenses), net  (179,447)  (770,053)
         
Loss before income tax provision  (1,884,441)  (2,093,630)
         
Income tax provision  -   - 
         
Net loss $(1,884,441) $(2,093,630)
Per-share data        
Basic and diluted loss per share $(0.01) $(0.05)
         
Weighted average number of common shares outstanding  133,830,595   39,930,275 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.


3

Jerrick Media Holdings, Inc.

Condensed Consolidated Statement of Changes in Stockholders’ Equity

For the Three Months ended March 31, 2018

  Series A Preferred Stock  Series B
Preferred Stock
  Common Stock  Treasury stock  Additional Paid In  Accumulated  Stockholders’ 
  Shares  Amount  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Equity 
                                  
Balance, December 31, 2017  31,581   31   8,063   8   39,520,682   39,521   (220,000)  (19,007)  14,387,247   (22,247,551)  (7,839,751)
                                             
Common stock issued to settle vendor liabilities  -   -   -   -   18,750   19   -   -   3,356   -   3,375 
                                             
Stock based compensation  -   -   -   -   -   -   -   -   214,782   -   214,782 
                                             
Stock warrants issued with note payable  -   -   -   -   -   -   -   -   897,006   -   897,006 
                                             
Issuance of common stock for prepaid services                  610,000   610   -   -   115,690   -   116,300 
                                             
Common stock issued with note payable  -   -   -   -   375,000   375   -   -   77,112   -   77,487 
                                             
BCF issued with note payable  -   -   -   -   -   -   -   -   38,413   -   38,413 
                                             
Dividends  -   -   -   -   -   -   -   -   -   (57,033)  (57,033)
                                             
Net loss for the three months  ended March 31, 2018  -   -   -   -   -   -   -   -   -   (2,093,631)  (2,093,631)
                                             
Balance, March 31, 2018  31,581   31   8,063   8   40,524,432   40,525   (220,000)  (19,007)  15,733,606   (24,398,215)  (8,643,052)

See accompanying notes to the consolidated financial statements

4

Jerrick Media Holdings, Inc.

Consolidated Statement of Changes in Stockholders’ Equity

For the Three Months Ended March 31, 2019

  Series A Preferred Stock  Series B Preferred Stock  Series D Preferred Stock  Common Stock  Treasury stock  Additional
Pain In
  Accumulated  Stockholders’ 
  Shares  Amount  Shares  Amount  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Equity 
                                        
Balance, December 31, 2018  -   -   -   -   -   -   129,506,802   129,507   (553,334)  (52,341)  33,977,295   (36,545,065)  (2,490,604)
                                                     
Stock based compensation  -   -   -   -   -   -   2,500,000   2,500   -   -   308,808   -   311,308 
                                                     
Cash received for common stock and warrants  -   -   -   -   -   -   2,599,320   2,599   -   -   647,230   -   649,829 
                                                     
Stock issuance cost  -   -   -   -   -   -   -   -   -   -   (143,146)  -   (143,146)
                                                     
Stock warrants issued with note payable  -   -   -   -   -   -   -   -   -   -   175,425   -   175,425 
                                                     
Purchase of treasury stock  -   -   -   -   -   -   -   -   (1,680,000)  (168,440)  (1,560)  -   (170,000)
                                                     
Net loss for the three months ended March  31, 2019  -   -   -   -   -   -   -   -   -   -   -   (1,884,441)  (1,884,441)
                                                     
Balance, March  31, 2019  -   -   -   -   -   -   134,606,122   134,606   (2,233,334)  (220,781)  34,964,052   (38,429,506)  (3,551,629)

See accompanying notes to the consolidated financial statements

5

Jerrick Media Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

  For the Nine Months Ended  For the Nine Months Ended 
  September 30,
2018
  September 30,
2017
 
     (revised) 
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $(10,052,160) $(6,377,874)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation  33,109   28,211 
Accretion of debt discount and issuance cost  2,039,589   1,560,239 
Share-based compensation  329,857   751,215 
Loss on settlement of vendor liabilities  (2,886)  110,674 
Gain on settlement of debt  (15,275)  (2,079)
Change in fair value of derivative liability  -   64,347 
Loss on extinguishment of debt  3,370,505   889,097 
Changes in operating assets and liabilities:      - 
Prepaid expenses  3,366   10,000 
Accounts receivable  (5,632)  - 
Security deposit  164   - 
Accounts payable and accrued expenses  848,171   489,326 
Deferred rent  3,429   - 
Net Cash Used In Operating Activities  (3,447,763)  (2,476,844)
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Cash paid for property and equipment  (24,084)  - 
Net Cash Used In Investing Activities  (24,084)  - 
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Net proceeds from issuance of notes  791,833   1,141,585 
Repayment of notes  (214,939)  (100,000)
Proceeds from issuance of demand loan  50,000   - 
Proceeds from issuance of convertible note  1,525,154   1,066,500 
Repayment of convertible notes  (86,798)  (477,777)
Proceeds from issuance of convertible notes - related party  299,852   555,000 
Proceeds from issuance of note payable - related party  315,000   479,000 
Repayment of note payable - related party  (163,305)  (120,000)
Investor Deposit  208,428   - 
Proceeds from issuance of common stock  1,155,832   - 
Proceeds from issuance of line of credit - related party  -   130,000 
Repayment of line of credit  (44,996)  (125,324)
Cash paid to preferred holder  (87,111)  - 
Cash paid for debt issuance costs  (166,761)  (151,956)
Cash paid for stock issuance costs  (35,115)  - 
Net Cash Provided By Financing Activities  3,547,074   2,397,028 
         
Net Change in Cash  75,227   (79,816)
         
Cash - Beginning of Year  111,051   174,494 
         
Cash - End of Year $186,278  $94,678 
         
SUPPLEMENTARY CASH FLOW INFORMATION:        
Cash Paid During the Year for:        
Income taxes $-  $- 
Interest $64,892  $3,534 
         
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Settlement of vendor liabilities $3,750  $353,732 
Beneficial conversion feature on convertible notes $38,413  $- 
Deemed dividends $174,232  $203,365 
Warrants issued with debt $1,122,292  $1,542,523 
Issuance of common stock for prepaid services $116,300  $- 
Conversion of note payable and interest into convertible notes $341,442  $- 
Warrants issued with amendment to notes payable $135,596  $- 
Inducement to convert convertible preferred stock $2,016,634  $- 

  For the Three Months Ended  For the Three Months Ended 
  March 31, 2019  March 31, 2018 
       
       
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $(1,884,441) $(2,093,630)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation  3,133   10,423 
Accretion of debt discount and issuance cost  47,364   174,888 
Share-based compensation  318,636   232,635 
Gain on settlement of vendor liabilities  -   (1,875)
Gain on settlement of debt  -   (13,452)
Amortization of right-of-use asset  11,935   - 
Loss on extinguishment of debt  77,514   342,366 
Changes in operating assets and liabilities:        
Prepaid expenses  -   (18,802)
Accounts receivable  (1,066)  (1,521)
Deferred revenue  (9,005)  - 
Accounts payable and accrued expenses  (6,687)  244,619 
Current portion of operating lease payable  (18,436)  - 
Net Cash Used In Operating Activities  (1,461,053)  (1,124,349)
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Cash paid for property and equipment  (2,801)  - 
Net Cash Used In Investing Activities  (2,801)  - 
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Cash overdraft  (33,573)  - 
Net proceeds from issuance of notes  -   50,000 
Repayment of notes  (50,000)  (76,500)
Proceeds from issuance of demand loan  300,000   - 
Proceeds from issuance of convertible note  787,813   1,080,452 
Repayment of convertible notes  (12,508)  (71,500)
Proceeds from issuance of convertible notes - related party  -   265,452 
Proceeds from issuance of note payable - related party  380,000   135,000 
Repayment of note payable - related party  (125,000)  (125,000)
Proceeds from issuance of common stock and warrants  649,829   - 
Repayment of line of credit  -   (25,000)
Cash paid for debt issuance costs  -   (97,500)
Purchase of treasury stock and warrants  (170,000)    
 Net Cash Provided By Financing Activities  1,726,561   1,135,404 
         
Net Change in Cash  262,707   11,055 
         
Cash - Beginning of Year  -   111,051 
         
Cash - End of Year $262,707  $122,106 
         
SUPPLEMENTARY CASH FLOW INFORMATION:        
Cash Paid During the Year for:        
Income taxes $-  $- 
Interest $-  $37,472 
         
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Settlement of vendor liabilities $-  $3,750 
Deferred offering costs $143,146  $- 
Debt discount on convertible note $-  $1,006,753 
Debt discount on related party note payable $-  $198,702 
Debt discount on note payable $-  $483,745 
Beneficial conversion feature on convertible notes $-  $38,413 
Accrued dividends $-  $57,032 
Warrants issued with debt $97,911  $554,639 
Issuance of common stock for prepaid services $-  $116,300 
Operating Lease liability $278,729  $- 
Option liability $7,328  $- 
Conversion of note payable and interest into convertible notes $-  $341,442 
Warrants with amendment to notes payable $-  $135,596 
Conversion of note payable - related party and interest into convertible notes - related party $-  $801,026 
Reclassification of derivative liability to equity $-  $356,288 
Debt discount paid in the form of common shares $-  $34,725 
Conversion of note payable and interest into convertible notes $-  $700,383 
Conversion of note payable- related party and interest into convertible notes- related party $-  $327,893 

  

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


Jerrick Media Holdings, Inc.

September 30,March 31, 2019 and 2018 and 2017

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

 

Note 1 – Organization and Operations

 

Jerrick Media Holdings, Inc. (“we,” “us,” the “Company,” or “Jerrick Media” or “Jerrick”) (formerly Great Plains Holdings, Inc. or “GTPH”) was incorporated under the laws of the state of Nevada on December 30, 1999 under the name LILM, Inc. The Company changed its name on December 3, 2013 to Great Plains Holdings, Inc. as part of its plan to diversify its business through the acquisition and operation of commercial real estate, including, but not limited to, self-storage facilities, apartment buildings, 55+ senior manufactured home communities, and other income producing properties. Historically, the Company has principally engaged in the manufacture and marketing of the LiL Marc, a plastic boys’ toilet-training device, which we discontinued as of December 31, 2014.

 

On February 5, 2016 (the “Closing Date”), GTPH, GPH Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of GTPH (“Merger Sub”), and Jerrick Ventures, Inc., a privately-held Nevada corporation headquartered in New Jersey (“Jerrick”), entered into an Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into Jerrick, with Jerrick surviving as a wholly-owned subsidiary of GTPH (the “Merger”). GTPH acquired, through a reverse triangular merger, all of the outstanding capital stock of Jerrick in exchange for issuing Jerrick’s shareholders (the “Jerrick Shareholders”), pro-rata, a total of 28,500,000 shares of GTPH’s common stock. GTPH assumed 33,415 shares of Jerrick’s Series A Convertible Preferred Stock (the “Jerrick Series A Preferred”) and 8,064 shares of Series B Convertible Preferred Stock (the “Jerrick Series B Preferred”).

   

In connection with the Merger, on the Closing Date, GTPH and Kent Campbell entered into a Spin-Off Agreement (the “Spin-Off Agreement”), pursuant to which Mr. Campbell purchased from GTPH (i) all of GTPH’s interest in Ashland Holdings, LLC, a Florida limited liability company, and (ii) all of GTPH’s interest in Lil Marc, Inc., a Utah corporation, in exchange for the cancellation of 781,818 shares of GTPH’s Common Stock held by Mr. Campbell. In addition, Mr. Campbell assumed all debts, obligations and liabilities of GTPH, including any existing prior to the Merger, pursuant to the terms and conditions of the Spin-Off Agreement.

 

Upon closing of the Merger on February 5, 2016, the Company changed its business plan to that of Jerrick Media.

 

Effective February 28, 2016, GTPH entered into an Agreement and Plan of Merger (the “Statutory Merger Agreement”) with Jerrick, pursuant to which GTPH became the parent company of Jerrick Ventures, LLC, a wholly-owned operating subsidiary of Jerrick (the “Statutory Merger”) and GTPH changed its name to Jerrick Media Holdings, Inc. to better reflect its new business strategy.

 

Jerrick Media is a technology company focused on the development of digital communities, marketing branded digital content, and e-commerce opportunities. Jerrick’s content distribution platform, Vocal, delivers a robust long-form, digital publishing platform organized into highly engaged niche-communities capable of hosting all forms of rich media content. Through Jerrick’s proprietary algorithm dynamics, Vocal enhances the visibility of content and maximizes viewership, providing advertisers access to target markets that most closely match their interests.

  

Note 2 – Significant and Critical Accounting Policies and Practices

 

Management of the Company is responsible for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application. Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial condition and results and require management’s most difficult, subjective, or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain. The Company’s significant and critical accounting policies and practices are disclosed below as required by generally accepted accounting principles.


7

Basis of Presentation - Unaudited Interim Financial Information

 

The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) with respect to Form 10-Q and Article 108 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s annual report on Form 10-K for the year ended December 31, 2017.2018.

 

Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company’s critical accounting estimates and assumptions affecting the financial statements were:

   

(i)Assumption as a going concern: Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
  
(ii)Fair value of long-lived assets: Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.
  
(iii)  Valuation allowance for deferred tax assets: Management assumes that the realization of the Company’s net deferred tax assets resulting from its net operating loss (“NOL”) carry–forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.
  
(iv)Estimates and assumptions used in valuation of equity instruments: Management estimates expected term of share options and similar instruments, expected volatility of the Company’s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk-free rate(s) to value share options and similar instruments.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.


Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

 

Actual results could differ from those estimates.

 

Principles of consolidation

 

The Company consolidates all majority-owned subsidiaries, if any, in which the parent’s power to control exists.

 

As of September 30, 2018,March 31, 2019, the Company’s consolidated subsidiaries and/or entities are as follows:

 

Name of combined affiliate State or other jurisdiction of
incorporation or organization
 Company interest 
       
Jerrick Ventures LLC The State of Delaware  100% 
Jerrick Australia Pty Ltd Australia  100% 

 

All inter-company balances and transactions have been eliminated.

 

Jerrick Australia Pty Ltd does not have any operations.

  

Fair Value of Financial Instruments

 

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

 

Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
   
Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
   
Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 


The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. 


The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses, accounts payable and accrued liabilities and accrued liquidating damages approximate their fair value because of the short maturity of those instruments. Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.

  

Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

 

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.

 

Property and Equipment

 

Property and equipment are recorded at cost. Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Depreciation is computed by the straight-line method (after taking into account their respective estimated residual values) over the estimated useful lives of the respective assets as follows:

 

  Estimated Useful
Life
(Years)
   
Computer equipment and software 3
Furniture and fixture5
Leasehold improvement 5

 

Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the condensed consolidated statements of operations.

 

Commitments and Contingencies

 

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the condensed consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

  

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. 

   


Derivative Liability

The Company evaluates its debt and equity issuances to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 815-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the condensed consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity.


In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

 

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions. The Company changed its method of accounting for the debt and warrants through the early adoption of ASU 2017-11 during the year ended December 31, 2017 on a retrospective basis.

 

The Company utilizes an option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The Company records the change in the fair value of the derivative as other income or expense in the condensed consolidated statements of operations.

Revenue Recognition

 

The CompanyOn January 1, 2018, we adopted ASC 606,Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers” (“ASC 606”)Customers (Topic 606), effective January 1, 2018which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, Revenue Recognition (Topic 605), using the modified retrospective transition method applied to those contracts which would require a cumulative effect adjustmentwere not completed as of January 1, 2018. Results for initially applying the new revenue standard as an adjustment to the opening balance of retained earnings and the comparative information wouldreporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts have not require to be restatedbeen adjusted and continue to be reported in accordance with our historic accounting under the accounting standards in effect for those periods.

Based on the Company’s analysis the Company did not identify a cumulative effect adjustment for initially applyingTopic 605. The impact of adopting the new revenue standards. During the nine months ended September 30, 2018 the Company recorded revenue from the following sources: products at auction, sponsored contentstandard was not material to our condensed consolidated financial statements and affiliate sites.there was no adjustment to beginning retained earnings on January 1, 2018.

 

The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company’s services and will provide financial statement readers with enhanced disclosures. In accordance with ASCUnder Topic 606, revenue is recognized when a customer obtains control of the promised services. Thegoods or services is transferred to our customers, in an amount of revenue recognizedthat reflects the consideration to which the Company expectswe expect to be entitled to receive in exchange for thesethose goods or services. To achieve this core principle, the Company applies

We determine revenue recognition through the following five steps:

 

1)Identifyidentification of the contract, or contracts, with a customercustomer;

 

A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

2)Identifyidentification of the performance obligations in the contractcontract;

 

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.

determination of the transaction price;

 

3)Determine the transaction price

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amountallocation of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts as of September 30, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below. 


4)Allocate the transaction price to the performance obligations in the contractcontract; and

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. For example, a bonus or penalty may be associated with one or more, but not all, distinct services promised in a series of distinct services that forms part of a single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

5)Recognizerecognition of revenue when, or as, the Company satisfieswe satisfy a performance obligationobligation.

  


The Company satisfies performance obligations either over time or atRevenue disaggregated by revenue source for the three months ended March 31, 2019 and 2018 consists of the following:

  Three Months Ended March 31, 
  2019  2018 
Branded content $20,071  $11,157 
Affiliate sales  3,122   1,874 
Other revenue  11,141   3,218 
  $34,334  $16,249 

Branded Content

Branded content represents the revenue recognized from the Company’s obligation to create and publish branded articles for a point in time. Revenue is recognized atclient on the timeVocal platform and promote stories, tracking engagement for the relatedclient. The performance obligation is satisfied by transferringwhen the Company successfully publishes the articles on its platform and meets any required promotional milestones as contractually agreed upon with such client. The revenue is recognized over time as the services are performed.

Below are the significant components of a promised servicetypical agreement pertaining to branded content revenue:

The Company will collect fixed fees ranging from $1,000 to $15,000

The articles are created and published within three months of the signed agreement, or as previously negotiated with the client

The articles are promoted per the contract and engagement reports are provided to the client

The client pays 50% at signing and 50% upon completion

Most contracts include provisions for clients to acquire content rights at the end of the campaign for a flat fee

Affiliate sales

Affiliate sales represents the commission the Company receives when a customer.purchase is made through affiliate links placed within content hosted on the Vocal platform. Affiliate revenue is earned on a “click through” basis, upon referring visitors, via said links, to an affiliate’s site and having them complete a specific outcome, most commonly a product purchase. The Company uses multiple affiliate platforms, such as Skimlinks, to form and maintain thousands of vendor relationships. Each vendor establishes their own commission percentage, which typically range from 2-20%. The revenue is recognized upon receipt as reliable estimates could not be made.

 

ProductDeferred Revenue

Deferred revenue consists of billings and payments from clients in advance of revenue recognition. As of March 31, 2019, the Company had deferred revenue of $0.

 

RevenueAccounts Receivable and Allowances

Accounts receivable are recorded and carried when the Company uploads the articles and reaches the required number of views on the platform. We make estimates for the allowance for doubtful accounts and allowance for unbilled receivables based upon our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect our ability to collect from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, providedcustomers. The Company did not record an allowance during the elements have value on a stand-alone basis.three months ended March 31, 2019 and 2018.


Stock-Based Compensation

 

The Company recognizesWe have stock-based compensation expenseplans that are broad-based long-term retention programs intended to attract and retain talented employees and align stockholder and employee interests, which allows for all equity–based payments grantedawards of restricted stock, restricted stock units and other stock-based awards of our common stock to employees in accordance with ASC 718 “Compensation – Stock Compensation”. Underand non-employees. Our plans include time-based, market-based, and performance-based awards of our common stock to employees and non-employees.

We account for stock-based awards under the fair value recognition provisions, the Company recognizes equity–based compensation netmethod of an estimated forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award. 

Restricted stock awards are granted at the discretion of the Company. These awards are restricted as to the transfer of ownership and generally vest over the requisite service periods, typically over a five-year period (vesting on a straight–line basis).accounting. The fair value of all stock-based compensation is recognized as expense on a straight-line basis over the full vesting period of the awards for time-based stock award is equal to the fair market value of a share of Companyawards and on an accelerated attribution method for market-based and performance-based stock on the grant date. awards.

 

TheWe estimate the fair value of an option award is estimatedtime-based awards using our closing stock price on the date of grant using the Black–Scholes option valuation model. The Black–Scholes option valuation model requires the development of assumptions that are inputs into the model. These assumptions are the value of the underlying share, the expected stock volatility, the risk–free interest rate, the expected life of the option, the dividend yield on the underlying stock and the expected forfeiture rate. Expected volatility is benchmarked against similar companies in a similar industry over the expected option life and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on its Common stock and does not intend to pay dividends on its Common stock in the foreseeable future. The expected forfeiture rate is estimated based on management’s best estimate.  

Determining the appropriate fair value model and calculatinggrant. We estimate the fair value of equity–market-based awards using a Black Scholes option valuation method, which takes into account assumptions such as the expected volatility of our common stock, the risk-free interest rate based payment awards requireson the inputcontractual term of the subjective assumptions described above. The assumptions used in calculating the fair value of equity–based payment awards represent management’s best estimates, which involve inherent uncertaintiesaward, expected dividend yield, vesting schedule and the application of management’s judgment. As a result, if factors change andprobability that the Company uses different assumptions, our equity–based compensation could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and recognize expense only for those shares expected to vest. If the Company’s actual forfeiture rate is materially different from its estimate, the equity–based compensation could be significantly different from what the Company has recorded in the current period.

The Company accounts for share–based payments granted to non–employees in accordance with ASC 505-40, “Equity Based Payments to Non–Employees”. The Company determines the fair valuemarket conditions of the stock–based payment as eitherawards will be achieved. For performance-based shares, we do not record expense until the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. If the fair value of the equity instruments issued is used, it is measured using the stock price and other measurement assumptions as of the earlier of either (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty’s performance is complete. The fair value of the equity instruments is re-measured each reporting period over the requisite service period. 


Income Taxes

Income taxescriteria are provided in accordance with ASC No. 740, “Accounting for Income Taxes”. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. 

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.considered probable.  

  

Loss Per Share

 

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, which is the case for the ninethree months ended September 30,March 31, 2019 and 2018 and 2017 presented in these condensed consolidated financial statements, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive.


The Company had the following common stock equivalents at September 30, 2018March 31, 2019 and 2017:2018:

 

 September 30,
2018
  September 30,
2017
  March 31,
2019
  March 31,
2018
 
Series A Preferred stock  -   21,654,614   -   192,567 
Series B Preferred stock  -   4,431,987   -   40,929 
Options  17,649,990   17,749,990   17,649,990   17,649,990 
Warrants  103,341,735   34,457,024   116,346,622   55,521,987 
Convertible notes - related party  2,000   -   1,012,626   9,526,533 
Convertible notes  1,620,505   13,681,425   3,760,784   23,796,858 
Totals  122,614,230   91,975,040   138,770,022   106,728,864 

 

Reclassifications

 

Interest expense hasCertain prior year amounts in the condensed consolidated financial statements and the notes thereto have been allocated to accretion of debt discount and issuance costreclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period presentation.total assets, total liabilities, stockholders’ deficit, net loss or net cash used in operating activities.

  

Recently Adopted Accounting Guidance

  

In AprilFebruary 2016, the FASB issued ASU No. 2016-10,2016-02, “Leases (Topic 842).” Under ASU 2016-02, lessees will, among other things, require lessees to recognize a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model and ASC Topic 606, “Revenue from Contracts with Customers: Identifying Performance ObligationsCustomers.” ASU 2016-02 became effective for us on January 1, 2019 and Licensing” (topic 606).initially required transition using a modified retrospective approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. In March 2016,July 2018, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net)2018-11, “Leases (Topic 842) - Targeted Improvements,(topic 606). These amendments providewhich, among other things, provides an additional clarification and implementationtransition method that would allow entities to not apply the guidance on the previously issued ASU 2014-09, “Revenue from Contracts with Customers”. The amendments in ASU 2016-10 provide clarifying guidance on materiality of performance obligations; evaluating distinct performance obligations; treatment of shipping2016-02 in the comparative periods presented in the financial statements and handling costs; and determining whether an entity’s promise to grantinstead recognize a license provides a customer with either a right to use an entity’s intellectual property or a right to access an entity’s intellectual property. The amendments in ASU 2016-08 clarify how an entity should identify the specified good or service for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements. The adoption of ASU 2016-10 and ASU 2016-08 is to coincide with an entity’s adoption of ASU 2014-09, which we adopted for interim and annual reporting periods beginning after December 15, 2017. The adoption of ASU 2016-10 did not have a material effect on its financial position or results of operations or cash flows.

Revenue Recognition

The Company adopted ASC 606 effective January 1, 2018 using the modified retrospective method which would require a cumulative effect adjustment for initially applying the new revenue standard as ancumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In December 2018, the FASB also issued ASU 2018-20, “Leases (Topic 842) - Narrow-Scope Improvements for Lessors,” which provides for certain policy elections and changes lessor accounting for sales and similar taxes and certain lessor costs. As of January 1, 2019, the comparative information would not require to be restatedCompany adopted ASU 2016-02 and continue to be reported under the accounting standards in effect for those periods.


Basedhas recorded a right-of-use asset and lease liability on the Company’s analysis the Company didbalance sheet for its operating leases. We elected to apply certain practical expedients provided under ASU 2016-02 whereby we will not identify a cumulative effect adjustment for initially applying the new revenue standards. During the six months ended June 30, 2018 the Company recorded revenue from the following sources: products at auction, sponsored content and affiliate sites.

The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company's services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:

1)Identify the contract with a customer

A contract with a customer exists whenreassess (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services,whether any expired or existing contracts are or contain leases, (ii) the contract has commercial substancelease classification for any expired or existing leases and (iii) initial direct costs for any existing leases. We also do not expect to apply the Company determines that collectionrecognition requirements of substantially all considerationASU 2016-02 to any short-term leases (as defined by related accounting guidance). We expect to account for services that are transferred is probable based on the customer’s intentlease and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

2)Identify the performance obligations in the contract

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources thatnon-lease components separately because such amounts are readily available from third parties or from the Company,determinable under our lease contracts and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.

3)Determine the transaction price

The transaction price is determined based on the consideration to which the Companybecause we expect this election will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company's contracts as of June 30, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below.

4)Allocate the transaction price to performance obligations in the contract

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. For example, a bonus or penalty may be associated with one or more, but not all, distinct services promised in a series of distinct services that forms part of a single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

5)Recognize revenue when or as the Company satisfies a performance obligation

The Company satisfies performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised service to a customer.

Product revenue

Revenue from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, provided the elements have value on a stand-alone basis.

Adoption of ASU 2017-11

As noted above, in connection with the securities purchase agreement and debt transactions during the year ended December 31, 2017, the Company issued warrants and convertible notes, to purchase common stock with an exercise price of $0.20 and a five-year term. Upon issuance of the warrants and convertible notes, the Company evaluated the note agreement to determine if the agreement contained any embedded components that would qualify the agreement as a derivative. The Company identified certain put features embedded in the warrants and convertible notes that potentially could result in a net cash settlement in the event of a fundamental transaction, requiring the Company to classify the warrants and convertible notes as a derivative liability. The Company changed its method of accounting for the convertible notes and warrants through the early adoption of ASU 2017-11 during the three months ended December 31, 2017lower impact on a retrospective basis. Accordingly, the Company recorded the warrant derivative and conversion option derivative liabilities to additional paid in capital upon issuance.our balance sheet.


Tabular summaries of the revisions and the corresponding effects on the statement of earnings for the nine months ended September 30, 2017 are presented below:

Consolidated Statement of Operations Nine Months Ended September 30, 2017
  Previously
Reported
  Revisions  Revised
Reported
 
Accretion of debt discount and issuance cost $(2,025,486) $499,972  $(1,525,514)
             
Derivative expense  (254,470)  254,470   - 
             
Change in fair value of derivative liabilities  1,257,716   (1,322,062)  (64,346)
             
Loss on extinguishment of debt  (876,038)  (47,784)  (923,822)
             
Net loss $(5,762,470) $(615,404) $(6,377,874)
             
Net loss per ordinary share:            
Basic and diluted loss per share $(0.15) $(0.02) $(0.17)

Tabular summaries of the revisions and the corresponding effects on the statement of earnings for the three months ended September 30, 2017 are presented below:

Consolidated Statement of Operations Three Months Ended September 30, 2017
  Previously
Reported
  Revisions  Revised
Reported
 
Accretion of debt discount and issuance cost $(1,074,002) $273,388  $(800,614)
             
Change in fair value of derivative liabilities  673,705   (738,051)  (64,346)
             
Loss on extinguishment of debt  (876,038)  (47,784)  (923,822)
             
Net loss $(2,909,519) $(512,446) $(3,421,965)
             
Net loss per ordinary share:            
Basic and diluted loss per share $(0.07) $(0.02) $(0.09)

 

Recent Accounting Guidance Not Yet Adopted

 

In February 2016, the FASB issued ASU 2016-02,“Leases (Topic 842).” Under ASU 2016-02, lessees will be required to recognize, for all leases of 12 months or more, a liability to make lease payments and a right-of-use asset representing the right to use the underlying asset for the lease term. Additionally, the guidance requires improved disclosures to help users of financial statements better understand the nature of an entity’s leasing activities. This ASU is effective for public reporting companies for interim and annual periods beginning after December 15, 2018, with early adoption permitted, and must be adopted using a modified retrospective approach. The Company is in the process of evaluating the effect of the new guidance on its condensed consolidated financial statements and disclosures.

In October 2016, the FASB issued ASU 2016-16,“Income “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory”, which eliminates the exception that prohibits the recognition of current and deferred income tax effects for intra-entity transfers of assets other than inventory until the asset has been sold to an outside party. The updated guidance is effective for annual periods beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption of the update is permitted. The Company is currently evaluating the impact of the new standard.

 

Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.


Note 3 – Going Concern

 

The Company’s condensed consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. 

 

As reflected in the condensed consolidated financial statements, the Company had an accumulated deficit at September 30, 2018,March 31, 2019, a net loss and net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.statements, or May 15, 2020.

 

The Company is attempting to further implement its business plan and generate sufficient revenues; however, its cash position may not be sufficient to support its daily operations. While the Company believes in the viability of its strategy to further implement its business plan and generate sufficient revenues and in its ability to raise additional funds by way of a public or private offering of its debt or equity securities, there can be no assurance to that effect. The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenues and its ability to raise additional funds by way of a public or private offering.

 

The condensed consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.     


Note 4 – Property and Equipment

Property and equipment stated at cost, less accumulated depreciation and amortization, consisted of the following:

  

September 30,

2018

  December 31,
2017
 
Computer Equipment $220,054  $234,315 
Furniture and Fixtures  61,803   61,803 
Leasehold Improvements  25,446   - 
   307,303   296,118 
Less: Accumulated Depreciation  (259,272)  (248,062)
  $48,031  $48,056 

Depreciation expense was $11,670 and $9,507 for the three months ended September 30, 2018 and 2017, respectively. Depreciation expense was $33,109 and $28,211 for the nine months ended September 30, 2018 and 2017, respectively.

  

Note 5 – Line of Credit

Line of credit as of September 30, 2018 and December 31, 2017 is as follows:

  Outstanding Balances as of 
  

September 30,

2018

  

December 31,

2017

 
Revolving Note            -   44,996 
  $-  $44,996 

On March 19, 2009, Astoria Surgical Supplies North LLC signed a revolving note (the “Revolving Note”) at PNC Bank (the “Bank”). The outstanding balance of this Revolving Note is limited to $200,000 and expired March 19, 2010. The outstanding balance accrues interest at a variable rate. The interest rate is subject to change based on changes in an independent index which is the highest Prime Rate as published in the “Money Rates” section of the Wall Street Journal. The Company had been in payment default since March 19, 2010; however, on May 3, 2017, the Company agreed to pay back the line of credit by December 1, 2017. On March 23, 2018 the Company sent the final payment for the Revolving Note and the Revolving Note was fully satisfied.

The balance outstanding on the Revolving Note at September 30, 2018 and December 31, 2017 was $0 and $44,996, respectively.

Note 64 – Notes Payable

 

Notes payable as of September 30, 2018March 31, 2019 and December 31, 20172018 is as follows:

 

  Outstanding Principal as of       Warrants 
  September 30,
2018
  December 31,
2017
  Interest Rate  Maturity Date Quantity  Exercise
Price
 
The February 2017 Offering $5,369  $400,000   12% September 1, 2017  2,450,000  $0.20 
The June 2017 Loan Agreement  -   50,000   12% September 1, 2017  35,000   0.20 
The First November 2017 Loan Agreement  -   100,000   15% January 12, 2018  -   - 
The Second November 2017 Loan Agreement  -   50,000   15% January 13, 2018  -   - 
The Third November 2017 Loan Agreement  -   100,000   15% January 13, 2018  -   - 
July 2018 Loan Agreement  100,000       6%  August 2018  300,000   - 
   105,369   700,000               
Less: Debt Discount  -   (10,500)              
Less: Debt Issuance Costs  (241)  -               
  $105,128  $689,500               


Private Placement Offerings:

The February 2017 Offering

From February 24, 2017 through March 17, 2017, the Company conducted multiple closings of a private placement offering (the “February 2017 Offering”) of the Company’s securities by entering into subscription agreements (the “Subscription Agreements”) with accredited investors (the “Accredited Investors”) for aggregate gross proceeds of $916,585 for which the Accredited Investors received $975,511 in principal value of secured promissory notes with an original issue discount of six percent (6%) (the “February 2017 Offering Notes”) and warrants to purchase the Company’s common stock (the “February 2017 Offering Warrants”).  

The February 2017 Offering Notes are convertible into shares of the Company’s common stock at the time of Company’s next round of financing (the “Subsequent Offering”) at a price equal to eighty-five percent (85%) of the price per share offered in the Subsequent Offering (the “Conversion Price”). The February 2017 Offering Warrants have a five-year term. Investors received the February 2017 Offering Warrants in the following amounts: (i) Investors purchasing $150,000 or more of the Offering received a February 2017 Offering Warrant equal to one hundred thirty percent (130%) of the dollar amount invested in the Offering; (ii) investors purchasing at least $100,000 but less than $150,000 of the February 2017 Offering received a February 2017 Offering Warrant equal to one hundred percent (100%) of the dollar amount invested in the Offering; and (iii) investors purchasing less than $100,000 of the Offering received to a February 2017 Offering Warrant equal to seventy percent (70%) of the dollar amount invested in the Offering. The February 2017 Offering Warrants entitle the holder to purchase shares of the Company’s common stock at $0.20 per share (the “Exercise Price”).

The Conversion Price and the Exercise Price are subject to adjustments for issuances of (i) the Company’s common stock, (ii) any equity linked instruments or (iii) securities convertible into the Company’s common stock, at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustments shall result in the Conversion Price or Exercise Price being reduced to such lower purchase price, as described in the February 2017 Offering Notes and the February 2017 Offering Warrants.

Pursuant to the Subscription Agreements, the February 2017 Offering Notes matured on September 1, 2017 (the “February 2017 Offering Maturity Date”). Prior to the February 2017 Offering Maturity Date, investors representing $575,511 in principal value converted their February 2017 Offering Notes into two year, 15% secured convertible promissory notes offered by the Company (the “August 2017 Convertible Note Offering”). The remaining investors representing an aggregate $400,000 in principal of the February 2017 Offering Notes agreed to forbear their right to declare an event of default until December 15, 2017 during which time they retain the right to convert their principal and any accrued but unpaid interest into the August 2017 Convertible Note Offering. In consideration of the forbearance for which the investors will receive a warrant to purchase up to fifteen percent (15%) of the shares of common stock underlying the warrant acquired with the purchase of the February 2017 Offering Notes at a purchase price of $0.20 per share, and the interest on their note would be increased to eighteen percent (18%) from September 1, 2017 through December 15, 2017 or the conversion date, whichever is sooner.

  Outstanding Principal as of       Warrants 
  March 31,
2019
  December 31,
2018
  Interest Rate  Maturity Date Quantity  Exercise
Price
 
July 2018 Loan Agreement              -   50,000   6%  August 2018  300,000       - 
       50,000               
Less: Debt Discount  -   -               
Less: Debt Issuance Costs  -   (74)              
  $-  $49,926               

 

During the ninethree months ended September 30, 2018March 31, 2019 the Company has repaid $131,606 of$50,000 in principal and $45,931 of unpaid$1,893 in interest. In addition, during the nine months ended September 30, 2018, the Company converted $263,025 of principal and $21,502 of unpaid interest into 1,422,639 shares of common stock. Upon conversion of the notes, the Company also issued 711,320 warrants with a grant date fair value of $102,954 which is recorded in Other income (expense) on the accompanying condensed consolidated statement of operations.

 

The June 2017 Loan Agreement

On June 12, 2017, the Company entered into a loan agreement (the “June 2017 Loan Agreement”) with an individual (the “June 2017 Lender”) whereby the June 2017 Lender issued the Company a promissory note of $50,000 (the “June 2017 Note”). Pursuant to the June 2017 Loan Agreement, the June 2017 Note bears interest at a rate of 10% per annum. As additional consideration for entering in the June 2017 Loan Agreement, the Company issued the June 2017 Lender a five-year warrant to purchase 35,000 shares of the Company’s common stock with an exercise price of $0.20 per share. The maturity date of the June 2017 Note was September 1, 2017 (the “June 2017 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the June 2017 Note were due.

During the nine months ended September 30, 2018 the Company has repaid $50,000 principal and the debtor has forgiven the interest of $4,424 this was recorded as a gain on forgiveness of debt on the accompanying condensed consolidated statement of operations.


The First November 2017 Loan Agreement

On November 28, 2017, the Company entered into a loan agreement (the “First November 2017 Loan Agreement”) with an individual (the “First November 2017 Lender”), the First November 2017 Lender issued the Company a promissory note of $100,000 (the “First November 2017 Note”). Pursuant to the First November 2017 Loan Agreement, the First November 2017 Note has interest of fifteen percent (15%), (i) five percent (5%) (i.e. $5,000) shall be payable in cash or convertible into shares of the Company’s restricted common stock at a rate of $0.20 per share, at the option of the Lender, at the Maturity Date; (ii) ten percent (10%) (i.e. $10,000) shall be paid in the form of the Company’s restricted common stock at a rate of $0.20 per share (equivalent to 50,000 shares of the Company’s common stock ). The maturity date of the First November 2017 Note was January 12, 2018 (the “First November 2017 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the First November 2017 Note are due. On January 12, 2018, the First November 2017 Note and accrued but unpaid interest was converted into the Company’s August 2017 Convertible Note Offering.

The Second November 2017 Loan Agreement

On November 29, 2017, the Company entered into a loan agreement (the “Second November 2017 Loan Agreement”) with an individual (the “Second November 2017 Lender”), the Second November 2017 Lender issued the Company a promissory note of $50,000 (the “Second November 2017 Note”). Pursuant to the Second November 2017 Loan Agreement, the Second November 2017 Note has interest of fifteen percent (15%), (i) five percent (5%) (i.e. $2,500) shall be payable in cash or convertible into shares of the Company’s restricted common stock at a rate of $0.20 per share, at the option of the Lender, at the Maturity Date; (ii) ten percent (10%) (i.e. $5,000) shall be paid in the form of the Company’s restricted common stock at a rate of $0.20 per share (equivalent to 25,000 shares of the Company’s common stock ). The maturity date of the Second November 2017 Note was January 13, 2018 (the “Second November 2017 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the Second November 2017 Note are due. On January 12, 2018, the Second November 2017 Note and accrued but unpaid interest was converted into the Company’s August 2017 Convertible Note Offering. 

The Third November 2017 Loan Agreement

On November 29, 2017, the Company entered into a loan agreement (the “Third November 2017 Loan Agreement”) with an individual (the “Third November 2017 Lender”), the Third November 2017 Lender issued the Company a promissory note of $100,000 (the “Third November 2017 Note”). Pursuant to the Third November 2017 Loan Agreement, the Third November 2017 Note has interest of fifteen percent (15%), (i) five percent (5%) (i.e. $5,000) shall be payable in cash or convertible into shares of the Company’s restricted common stock at a rate of $0.20 per share, at the option of the Lender, at the Maturity Date; (ii) ten percent (10%) (i.e. $10,000) shall be paid in the form of the Company’s restricted common stock at a rate of $0.20 per share (equivalent to 50,000 shares of the Company’s common stock). The maturity date of the Third November 2017 Note was January 13, 2018 (the “Third November 2017 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the Third November 2017 Note are due. On January 12, 2018, the Third November 2017 Note and accrued but unpaid interest was converted into the Company’s August 2017 Convertible Note Offering.

On March 14, 2018, the Company entered into a loan agreement (the “March 2018 Loan Agreement”) with an individual (the “March 2018 Lender”), the March 2018 Lender issued the Company a promissory note of $50,000 (the “March 2018 Note”). Pursuant to the March 2018 Loan Agreement, the March 2018 Note bears interest at a rate of 12% per annum. As additional consideration for entering in the March 2018 Loan Agreement, the Company issued the March 2018 Lender a five-year warrant to purchase 100,000 shares of the Company’s common stock with an exercise price of $0.20 per share. The maturity date of the March 2018 Note was March 29, 2018 (the “March 2018 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the March 2018 Note were due. On March 29, 2018, the March 2018 Note and accrued but unpaid interest was converted into the Company’s March 2018 Convertible Note Offering.


The May 2018 Offering

During the months of May and June 2018, the Company conducted multiple closings with accredited investors (the “May 2018 Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”) for aggregate gross proceeds of $658,500.

The May 2018 Offering consisted of a maximum of $1,200,000 of units of the Company’s securities (each, a “Unit” and collectively, the “Units”), with each Unit consisting of (i) a 13% promissory note (each, a ” May 2018 Offering Note” and, together, the “May 2018 Offering Notes”), and (ii) a four-year warrant (“May 2018 Offering Warrant”) to purchase the number of shares of the Company’s common stock equal to three times the principal amount in dollars invested by such investor in each May 2018 Offering Note (the “May 2018 Warrant Shares”) at an exercise price of $0.20 per share (the “May Offering Warrant Exercise Price”), subject to adjustment upon the terms thereof. The May 2018 Offering Notes mature on the nine-month anniversary of their issuance dates.

The Company recorded a $215,032 debt discount relating to 1,825,500 May 2018 Offering Warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

The May Offering Warrant Exercise Price of the May 2018 Offering Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing May 2018 Offering Warrant Exercise Price. Such adjustment shall result in the May 2018 Offering Warrant Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

During the nine months ended September 30, 2018, the Company converted $608,500 of principal and $723,780 of unpaid interest into the August 2018 equity raise (as defined below).

July 2018 Loan Agreements

In July 2018, the Company received gross proceeds of $100,000 from the issuance of notes payable. As additional consideration for entering into the debentures, the Company issued the investor a 4-year warrant to purchase 300,000 shares of the Company’s common stock at a purchase price of $0.20 per share. The Company recorded a $34,569 debt discount relating to these warrants issued to these investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of this note to accretion of debt discount and issuance cost.

Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon agreements that extended the maturity dates of these loans to March 7, 2019. As part of the extension agreements, the Company issued 204,051 warrants to purchase common stock of the Company at an exercise price of $0.30.

August 2018 Loan Agreements

On August 30, 2018, the Company received gross proceeds of $33,333 from the issuance of a note payable. As additional consideration for entering into the debenture, the Company issued the investor a 4-year warrant to purchase 33,333 shares of the Company’s common stock at a purchase price of $0.20 per share. The Company recorded a $4,178 debt discount relating to these warrants issued to this investor based on the relative fair value of each equity instrument on the dates of issuance. The debt discount was fully accreted during the nine months ended September 30, 2018. On September 7, 2018 the Company has repaid $33,333 in principal.


Note 75 – Convertible Note Payable

 

Convertible notes payable as of September 30, 2018March 31, 2019 and December 31, 20172018 is as follows: 

 

  Outstanding Principal as of          Warrants 
  September 30,
2018
  December 31,
2017
  Interest
Rate
  Conversion
Price
  Maturity Date Quantity  Exercise
Price
 
The November 2016 Convertible Note Offering $-  $25,000   10%  0.30  November 1, 2017  400,000  $0.30 
The June 2017 Convertible Note Offering  -   71,500   12%  Not Applicable  September 1, 2017  114,700   0.20 
The August 2017 Convertible Note Offering  114,100   2,943,884   15%  0.20(*) August – November 2019  14,716,419   0.20 
The First December 2017 Note  -   100,000   15%  0.20(*) December 21, 2019  500,000   0.20 
The February 2018 Convertible Note Offering  75,000   -   15%  0.20(*) January – February 2020  5,078,375   0.20 
The January 2018
Note
  -   -       0.20(*) January 12, 2020  343,806   0.20 
The February 2018 Note  25,452   -   18%  0.20(*) February 8, 2020  81,500   0.20 
The March 2018 Convertible Note Offering  75,000   -   14%  0.20(*) March – April 2020  4,806,833   0.20 
   289,552   3,140,384                   
Less: Debt Discount  (46,367)  (452,022)                  
Less: Debt Issuance Costs  (16,681)  (79,569)                  
   226,504   2,608,793                   
Less: Current Debt  (40,401)  (96,500)                  
Total Long-Term Debt $186,103  $2,512,293                   

  Outstanding Principal as of          Warrants 
  March 31,
2019
  December 31,
2018
  Interest
Rate
  Conversion
Price
  Maturity Date Quantity  Exercise
Price
 
The February 2018 Convertible Note Offering  62,492   75,000   15%  0.20(*) January – February 2020  5,078,375   0.20 
The March 2018 Convertible Note Offering  75,000   75,000   14%  0.20(*) March – April 2020  4,806,833   0.20 
The February 2019 Convertible Note Offering  787,813   -   10%  0.25(*) February – March 2020  782,100   0.30 
   925,305   150,000                   
Less: Debt Discount  (79,585)  (17,280)                  
Less: Debt Issuance Costs  (9,240)  (9,239)                  
   836,480   123,481                   
Less: Current Debt  (761,480)  -                   
Total Long-Term Debt $75,000  $123,481                   

  

(*) As subject to adjustment as further outlined in the notes

(*)As subject to adjustment as further outlined in the notes

The November 2016 Convertible Note Offering

During the months of November and December 2016, the Company issued convertible notes to third party lenders totaling $400,000 (the “November 2016 Convertible Note Offering”). These notes accrue interest at a rate of 10% per annum and mature with interest and principal both due between November 1, 2017 through December 29, 2017. The notes and accrued interest are convertible at a conversion price as defined therein. In addition, in connection with these notes the Company issued five-year warrants to purchase an aggregate of 400,000 shares of Company common stock at a purchase price of $0.30 per share. These investors converted $375,000 of principal and $30,719 of interest into the August 2017 Convertible Note Offering. 

During the nine months September 2018, the Company converted $25,000 of principal and $4,417 of unpaid interest into the August 2018 Equity Raise (as defined below).

The June 2017 Convertible Note Offering

During the month of June 2017 the Company issued convertible notes to third party lenders totaling $71,500. These notes accrue interest at 12% per annum and mature with interest and principal both due on September 1, 2017. These notes and accrued interest may be converted into a subsequent offering at a 15% discount to the offering price are convertible at a conversion price as defined therein. In addition, the Company issued warrants to purchase 67,550 shares of Company common stock. These warrants entitle the holders to purchase the Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date. As of December 31, 2017, the Company was currently in default on $71,500 in principal due on these notes. On February 8, 2018, the Company repurchased these notes and is no longer in default.

The August 2017 Convertible Note Offering

From August through November of 2017, the Company conducted multiple closings of a private placement offering to accredited investors (the “August 2017 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”) for aggregate gross proceeds of $1,585,000. In addition, $1,217,177 of the Company’s short-term debt along with accrued but unpaid interest of $40,146 was converted into the August 2017 Convertible Note Offering. These conversions resulted in the issuance of 6,791,419 warrants with a fair value of $583,681 and an original issue discount of $101,561. These were recorded as a loss on extinguishment of debt. 

The August 2017 Convertible Note Offering consisted of a maximum of $6,000,000 of units of the Company’s securities (each, a “Unit” and collectively, the “Units”), with each Unit consisting of (a) a 15% Convertible Secured Promissory Note (each a “August 2017 Offering Note”, and together the “August 2017 Offering Notes”), convertible into shares of the Company’s common stock (“August 2017 Offering Conversion Shares”) at a conversion price of $0.20 per share (the “August 2017 Note Conversion Price”), and (b) a five-year warrant (each a “August 2017 Offering Warrant and together the “August 2017 Offering Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the August 2017 Offering Notes can be converted into (“August 2017 Offering Warrant Shares”) at an exercise price of $0.20 per share (“August 2017 Offering Warrant Exercise Price”). The August 2017 Offering Notes mature on the second (2nd) anniversary of their issuance dates.

The August 2017 Note Conversion Price and the August 2017 Offering Warrant Exercise Price are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing August 2017 Note Conversion Price or August 2017 Offering Warrant Exercise Price. Such adjustment shall result in the August 2017 Note Conversion Price and August 2017 Offering Warrant Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

The Company recorded a $472,675 debt discount relating to 7,925,000 August 2017 Offering Warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

In connection with the August 2017 Convertible Note Offering, the Company paid a placement agent a cash fee of $90,508 to for services rendered in connection therewith on a “best-efforts” basis, which was recorded as issuance cost and is being accreted over the life of the note to accretion of debt discount and issuance cost. 

During the nine months ended September 30, 2018, the Company converted $2,830,764 of principal and $409,287 of unpaid interest into the August 2018 Equity Raise (as defined below).


The First December 2017 Note

On December 27, 2017, the Company issued a convertible note to a third-party lender totaling $100,000 (the “First December 2017 Note”). The First December 2017 Note accrues interest at 15% per annum and matures with interest and principal both due on December 27, 2019. In addition, the Company issued a warrant to purchase 500,000 shares of Company common stock. The warrant entitles the holder to purchase the Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date. The Company recorded a $35,525 debt discount relating to the warrants issued to the investor based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note The First December 2017 Note and accrued interest is convertible at a conversion price of $0.20 per share, subject to adjustment. The First December 2017 Note is secured by a second priority lien on the assets of the Company.

During the nine months ended September 30, 2018, the Company converted $100,000 of principal and $10,292 of unpaid interest into the August 2018 Equity Raise (as defined below).

The February 2018 Convertible Note Offering

 

During the ninethree months ended September 30,March 31, 2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “February 2018 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”“February 2018 Investors”) for aggregate gross proceeds of $725,000. In addition, $250,000 of the Company’s short-term debt along with accrued but unpaid interest of $40,675 was converted intoexchanged for convertible debt in the February 2018 Offering. These conversions resulted in the issuance of warrants to purchase 1,453,375 warrantsshares of common stock with a fair value of $181,139. These were recorded as a loss on extinguishment of debt.

 

The February 2018 Convertible Note Offering consisted of a maximum of $750,000 of units of the Company’s securities (each, a “Unit”“February 2018 Unit” and collectively, the “Units”“February 2018 Units”), with each February 2018 Unit consisting of (a) a 15% Convertible Secured Promissory Note (each a “February 2018 Convertible Note” and together the “February 2018 Convertible Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“February 2018 Conversion Shares”) at a conversion price of $0.20 per share (the “February 2018 Note Conversion Price”), and (b) a five-year warrant (each a “February 2018 Offering Warrant and together the “February 2018 Offering Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the February 2018 Convertible Notes can be converted into (“February 2018 Warrant Shares”) at an exercise price of $0.20 per share (“February 2018 Warrant Exercise Price”). The February 2018 Offering Notes mature on the second (2nd) anniversary of their issuance dates. The February 2018 Offering Notes are secured by a second priority security interest in the Company’s assets up to $1,000,000.

 

The February 2018 Note Conversion Price and the February 2018 Offering Warrant Exercise Price are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

       

The conversion feature of the February 2018 Convertible Note Offering provides for an effective conversion price that is below market value on the date of issuance. Such feature is normally characterized as a beneficial conversion feature (“BCF”). When the Company records a BCF the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The Company recorded a BCF and related debt discount of $37,350, the discount is being accreted over the life of the first Debenture to accretion of debt discount and issuance cost.

 


The Company recorded a $316,875 debt discount relating to 3,625,000 February 2018 Offering Warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.

 

In connection with the February 2018 Convertible Note Offering, the Company retained a placement agent (the “Placement Agent”), to carry out the Offering on a “best-efforts” basis. For services in its capacity as Placement Agent, the Company has paid the Placement Agent a cash fee of $94,250 and issued to the Placement Agent shares of the Company’s common stock equal to ten percent (10%) of the Conversion Shares underlying the February 2018 Convertible Notes or 362,500 shares that had a fair value of $74,881, which was recorded as issuance cost and is being accreted over the life of these notes to accretion of debt discount and issuance cost.


During the nine monthsYear ended September 30,December31, 2018, the Company converted $940,675 of principal and $86,544 of unpaid interest into the August 2018 Equity Raise (as defined below).

 

The January 2018 Note

On January 12, 2018, the Company issued a convertible note to a third-party lender totaling $68,761 to settle an outstanding vendor liability (the “January 2018 Note”). The January 2018 Note accrues interest at 15% per annum and matures with interest and principal both due on January 12, 2020. The conversions resulted in the issuance of 343,806 warrants with a fair value of $42,850. These were recorded as a loss on extinguishment of debt. The warrant entitles the holder to purchase the Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date. The January 2018 Note and accrued interest is convertible at a conversion price of $0.20 per share, subject to adjustment. The January 2018 Note is secured by a second priority lien on the assets of the Company.

During the ninethree months ended September 30, 2018,March 31, 2019 the Company converted $68,761 of principal and $7,212 of unpaid interest into the August 2018 Equity Raise (as defined below).

The February 2018 Note

On February 8, 2018, the Company issued a convertible note to a third-party lender totaling $40,750 (the “February 2018 Note”). The February 2018 Note accrues interest at 18% per annum and matures with interest and principal both due on February 8, 2020. In addition, the Company issued a warrant to purchase 81,500 shares of Company common stock. The warrant entitles the holder to purchase the Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date. The Company recorded a $7,963 debt discount relating to the warrants issued to the investor based on the relative fair value of each equity instrument on the dates of issuance and an original issue discount of $5,298. The debt discount is being accreted over the life of the note. The February 2018 Note and accrued interest is convertible at a conversion price of $0.20 per share, subject to adjustment. The February 2018 Note is secured by a second priority lien on the assets of the Company. During the nine months ended September 30, 2018, the Company hascompany repaid $15,298$12,508 in principal.

 

The March 2018 Convertible Note Offering

 

During the ninethree months ended September 30,March 31, 2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “March 2018 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “March 2018 Investors”) for aggregate gross proceeds of $770,000. In addition, $50,000 of the Company’s short-term debt, $767 accrued but unpaid interest and $140,600 of the Company’s vendor liabilities was exchanged for convertible debt within the March 2018 Convertible Note Offering. These conversions resulted in the issuance of 956,833 warrants with a fair value of $84,087. These were recorded as a loss on extinguishment of debt.

The March 2018 Convertible Note Offering consisted of a maximum of $900,000, with an over-allotment option of an additional $300,000 of units of the Company’s securities (each, a “March 2018 Unit” and collectively, the “March 2018 Units”), with each March 2018 Unit consisting of (a) a 14% Convertible Secured Promissory Note (each a “March 2018 Note” and together the “March 2018 Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion price of $0.20 per share (the “Conversion Price”), and (b) a four-year warrant (each a “Warrant and together the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can be converted into (“Warrant Shares”) at an exercise price of $0.20 per share (“Exercise Price”). The March 2018 Notes mature on the second (2nd) anniversary of their issuance dates. 

The Conversion Price of the March 2018 Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

The Company recorded a $254,788 debt discount relating to 4,806,833 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

During the Year ended December31, 2018, the Company converted $886,367 of principal and $51,293 of unpaid interest pursuant to the August 2018 Equity Raise (as defined below).

The February 2019 Convertible Note Offering

During the three months ended March 31, 2019, the Company conducted an offering to accredited investors (the “February 2019 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “February 2019 Investors”) for aggregate gross proceeds of $787,813.

The February 2019 Convertible Note Offering consisted of (a) a 10% Convertible Promissory Note (each a “February 2019 Note” and together, the “February 2019 Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i) a fixed conversion price equal to $0.25 per share or (ii) the price provided to investors in connection with (a) any private placement offerings or one or more registered public offerings by the Company under the Securities Act, pursuant to which the Company receives monies in the amount greater than $1,500,000 in exchange for securities of the Company between February 21, 2019 and the date on which the Company’s consummates a listing onto a national securities exchange, or (b) any private placement offerings or one or more registered public offerings by the Company under the Securities Act in connection with its listing onto a national securities exchange (a “Qualified Offering”), and (b) a four-year stock purchase warrant (each a “Warrant and together the “Warrants”) to purchase a quantity of shares of the Company’s common stock up to thirty-three percent (33%) of the number of shares of common stock into which the underlying February 2019 Notes may be converted, at an exercise price of $0.30 per share (“Exercise Price”). During the three months ended March 31, 2019 a total of 1,046,100 Warrants were issued in conjunction with The February 2019 Convertible Note Offering.

The February 2019 Notes mature on the first (1st) anniversary of their issuance dates. In the event that the Offering’s Purchasers do not choose to convert the February 2019 Notes into the Common Stock on or prior to the Maturity Dates, the principal and interest shall be mandatorily converted upon the earlier of (i) the listing of the Common Stock onto a national securities exchange, or (ii) upon a Qualified Offering (as defined therein).

The Conversion Price of the February 2019 Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s Common Stock or any equity linked instruments or securities convertible into the Company’s Common Stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.


The Company recorded a $73,214 debt discount relating to 1,046,100 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

Note 6 – Related Party Loans

Convertible notes

Convertible notes payable – related party as of March 31, 2019 and December 31, 2018 is as follows:

  Outstanding Principal as of       Warrants 
  March 31,
2019
  December 31,
2018
  Interest
Rate
  Maturity Date Quantity  Exercise
Price
 
The March 2018 Convertible Note Offering  400   400   14% March 2020  1,197,000   0.20 
   400   400               
Less: Debt Discount  (45)  (72)              
Less: Debt Issuance Costs  -   -               
   355   328               
Less: Current Debt  -   -               
Total Long-Term Debt $355  $328               

The March 2018 Convertible Note Offering

During the three months ended March 31, 2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “March 2018 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”) for aggregate gross proceeds of $770,000. In addition, $50,000 of the Company’s short-term debt, $767 accrued but unpaid interest and $140,600 of the Company’s vendor liabilities was converted into the March 2018 Convertible Note Offering. These conversions resulted in the issuance of 956,833 warrants with a fair value of $84,087. These were recorded as a loss on extinguishment of debt.$239,400.

 


The March 2018 Convertible Note Offering consisted of a maximum of $900,000, with an over-allotment option of an additional $300,000, of units of the Company’s securities (each, a “Unit”“March 2018 Unit” and collectively, the “Units”“March 2018 Units”), with each March 2018 Unit consisting of (a) a 14% Convertible Secured Promissory Note (each a “Note”“March 2018 Note” and together the “Notes”“March 2018 Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion price of $0.20 per share (the “Conversion Price”), and (b) a four-year warrant (each a “Warrant and together the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can be converted into (“Warrant Shares”) at an exercise price of $0.20 per share (“Exercise Price”). The Notes mature on the second (2nd) anniversary of their issuance dates. 

 

The Conversion Price of the Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

The Company recorded a $254,788 debt discount relating to 4,806,833 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

During the nine months ended September 30, 2018, the Company converted $886,367 of principal and $51,293 of unpaid interest into the August 2018 Equity Raise (as defined below).

Note 8 – Related Party Loans

Convertible notes

Convertible notes payable – related party as of September 30, 2018 and December 31, 2017 is as follows:

  Outstanding Principal as of       Warrants 
  September 30,
2018
  December 31,
2017
  Interest
Rate
  Maturity Date Quantity  Exercise
Price
 
The August 2017 Convertible Note Offering $-  $1,416,026   15% August – October 2019  4,589,466  $0.20 
The Second December 2017 Note  -   100,000   15% December 21,
2019
  500,000   0.20 
The February 2018 Convertible Note Offering  -   -   15% January – February 2020  125,000   0.20 
The Second February 2018 Note  -   -   20% September 30,
2018
  81,500   0.20 
The March 2018 Convertible Note Offering  400   -   14% March 2020  1,197,000   0.20 
   400   1,516,026               
Less: Debt Discount  (86)  (170,780)              
Less: Debt Issuance Costs  -   -               
   314   1,345,246               
Less: Current Debt  -   -               
Total Long-Term Debt $314  $1,345,246               


The August 2017 Convertible Note Offering

During the year ended December 31, 2017, the Company conducted multiple closings of a private placement offering to accredited investors (the “The August 2017 Convertible Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”) for aggregate gross proceeds of $505,000. In addition, $645,000 of the Company’s short-term debt along with accrued but unpaid interest of $206,026 was converted into the August 2017 Convertible Offering. These conversions resulted in the issuance of 4,555,129 warrants with a fair value of $440,157 and the increase of principal of $60,000. These resulted in a loss on extinguishment of debt of $500,157.

The Company offered, through a placement agent, $6,000,000 of units of its securities (each, a “Unit” and collectively, the “Units”), with each Unit consisting of (a) a 15% Convertible Secured Promissory Note (each a “Note” and together the “Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion price of $0.20 per share (the “Conversion Price”), and (b) a five-year warrant (each a “Warrant and together the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can be converted into (“Warrant Shares”) at an exercise price of $0.20 per share (“Exercise Price”). The Notes mature on the second (2nd) anniversary of their issuance dates. 

The Conversion Price of the Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

The Company recorded a $160,700 debt discount relating to 2,525,000 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.

During the nine months ended September 30, 2018, the Company converted $1,416,026 of principal and $202,362 of unpaid interest into the August 2018 Equity Raise (as defined below).

The Second December 2017 Note

On December 21, 2017, the Company issued a convertible note to a third-party lender totaling $100,000 (the “Second December 2017 Note”). The Second December 2017 Note accrues interest at 15% per annum and matures with interest and principal both due on December 27, 2019. In addition, the Company issued a warrant to purchase 500,000 shares of Company common stock. The warrant entitles the holder to purchase the Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date. The Company recorded a $36,722 debt discount relating to the warrants issued to the investor based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note The Second December 2017 Note and accrued interest is convertible at a conversion price of $0.20 per share, subject to adjustment. The Second December 2017 Note is secured as a second priority lien on the assets of the Company.

During the nine months ended September 30, 2018, the Company converted $100,000 of principal and $10,542 of unpaid interest into the August 2018 Equity Raise (as defined below). 

The February 2018 Convertible Note Offering

During the nine months ended September 30, 2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “February 2018 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”) for aggregate gross proceeds of $25,000.

The February 2018 Convertible Note Offering consisted of a maximum of $750,000 of units of the Company’s securities (each, a “Unit” and collectively, the “Units”), with each Unit consisting of (a) a 15% Convertible Secured Promissory Note (each a “Note” and together the “Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion price of $0.20 per share (the “Conversion Price”), and (b) a five-year warrant (each a “Warrant and together the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can be converted into (“Warrant Shares”) at an exercise price of $0.20 per share (“Exercise Price”). The Notes mature on the second (2nd) anniversary of their issuance dates. The Notes are secured by a second priority security interest in the Company’s assets up to $1,000,000.


The Conversion Price of the Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

The conversion feature of the February 2018 Convertible Note Offering provides for an effective conversion price that is below market value on the date of issuance. Such feature is normally characterized as a beneficial conversion feature (“BCF”). When the Company records a BCF the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The Company recorded a BCF and related debt discount of $1,063, the discount is being accreted over the life of the first Debenture to accretion of debt discount and issuance cost.

The Company recorded a $11,054 debt discount relating to 125,000 warrants issued to Investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

In connection with the Offering, the Company retained Network 1 Financial Securities, Inc. (the “Placement Agent”), to carry out the Offering on a “best-efforts” basis. For services in its capacity as Placement Agent, the Company has paid the Placement Agent a cash fee of $3,250 and issued to the Placement Agent shares of the Company’s common stock equal to ten percent (10%) of the Conversion Shares underlying the Notes or 12,500 shares that had a fair value of $2,606, which was recorded as issuance cost and is being accreted over the life of these notes to accretion of debt discount and issuance cost.

During the nine months ended September 30, 2018, the Company converted $25,000 of principal and $2,219 of unpaid interest into the August 2018 Equity Raise (as defined below).

The Second February 2018 Note

On February 8, 2018, the Company issued a convertible note to a third-party lender totaling $40,750 (the “Second February 2018 Note”). The Second February 2018 Note accrues interest at 18% per annum and matures with interest and principal both due on September 30, 2018. In addition, the Company issued a warrant to purchase 81,500 shares of Company common stock. The warrant entitles the holder to purchase the Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date. The Company recorded a $7,963 debt discount relating to the warrants issued to the investor based on the relative fair value of each equity instrument on the dates of issuance and an original issue discount of $5,298. The debt discount is being accreted over the life of the note The Second February 2018 Note and accrued interest is convertible at a conversion price of $0.20 per share, subject to adjustment. The Second February 2018 Note is secured as a second priority lien on the assets of the Company. 

During the nine months ended September 30, 2018, the Company has repaid $5,298 in principal. In addition, the Company converted $35,452 of principal and $4,116 of unpaid interest into the August 2018 Equity Raise (as defined below). 

The March 2018 Convertible Note Offering

During the nine months ended September 30, 2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “March 2018 Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the “Investors”) for aggregate gross proceeds of $239,400.

The March 2018 Convertible Note Offering consisted of a maximum of $900,000, with an over-allotment option of an additional $300,000, of units of the Company’s securities (each, a “Unit” and collectively, the “Units”), with each Unit consisting of (a) a 14% Convertible Secured Promissory Note (each a “Note” and together the “Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion price of $0.20 per share (the “Conversion Price”), and (b) a four-year warrant (each a “Warrant and together the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can be converted into (“Warrant Shares”) at an exercise price of $0.20 per share (“Exercise Price”). The Notes mature on the second (2nd) anniversary of their issuance dates.


The Conversion Price of the Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase price, subject to carve-outs as described therein.

The Company recorded a $84,854 debt discount relating to 1,197,000 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.

  

During the nine monthsyear ended September 30, 2018,December 31, 2019, the Company converted $239,000 of principal and $15,401 of unpaid interest into the August 2018 Equity Raise (as defined below).

 

Notes payable

 

Notes payable – related party as of September 30, 2018March 31, 2019 and December 31, 20172018 is as follows:

 

  Outstanding Principal as of       Warrants 
  September 30,
2018
  December 31,
2017
  Interest
Rate
  Maturity Date Quantity  Exercise
Price
 
The May 2016 Rosen Loan Agreement $1,000,000  $1,000,000   13% November 26, 2017  1,000,000  $0.40 
The September 2017 Rosen Loan Agreement  -   224,000   18% September 24, 2017  125,000   0.20 
The November 2017 Schiller Loan Agreement  -   25,000   15% December 31, 2017  -   - 
The May 2018 Schiller Loan Agreements  -   -   13% February 2, 2019  300,000   0.20 
The June 2018 Frommer Loan Agreement  10,000   -   6% August 17, 2018  30,000   0.20 
The July 2018 Rosen Loan Agreement  60,000   -   6% August 17, 2018  30,000   0.20 
The July 2018 Schiller Loan Agreements  60,000   -   6% August 17, 2018  150,000   0.20 
   1,130,000   1,249,000               
Less: Debt Discount  (14,400)  -               
   1,115,600                   
Less: Current Debt  (1,115,600)  -               
  $-  $1,249,000               

  Outstanding Principal as of       Warrants 
  March 31,
2019
  December 31,
2018
    Interest
Rate    
  Maturity Date Quantity  Exercise
Price
 
The May 2016 Rosen Loan Agreement $1,000,000  $1,000,000   13% November 26, 2017  1,000,000  $0.40 
The June 2018 Frommer Loan Agreement  10,000   10,000   6% August 17, 2018  30,000   0.20 
The July 2018 Rosen Loan Agreement  60,000   60,000   6% August 17, 2018  30,000   0.20 
The July 2018 Schiller Loan Agreements  40,000   40,000   6% August 17, 2018  150,000   0.20 
The December 2018 Gravitas Loan Agreement  -   50,000   6% January 22, 2019  50,000   0.30 
The December 2018 Rosen Loan Agreement  75,000   75,000   6% January 26, 2019  75,000   0.30 
The January 2019 Rosen Loan Agreement  175,000   -   10% February 15, 2019  300,000   0.30 
The February 2019 Gravitas Loan Agreement  -   -   5% February 28, 2019  7,500   0.30 
The February 2019 Rosen Loan Agreement  50,000   -   10% February 28, 2019  100,000   0.30 
The March 2019 Gravitas Loan Agreement  80,000   -   6% April 11, 2019  10,000   0.30 
   1,490,000   1,235,000               
Less: Debt Discount  (284)  (11,927)              
   1,489,716   1,223,073               
Less: Current Debt  (1,489,716)  (1,223,073)              
  $   $-               

19

 

The May 2016 Rosen Loan Agreement

 

On May 26, 2016, the Company entered into a loan agreement (the “May 2016 Rosen Loan Agreement”) with Arthur Rosen, an individual (“Rosen”), pursuant to which on May 26, 2016 (the “Closing Date”), Rosen provided the Company a secured term loan in the principal amount of $1,000,000 (the “May 2016 Rosen Loan”). In connection with the May 2016 Rosen Loan Agreement, on May 26, 2016, the Company and Rosen entered into a security agreement (the “Rosen Security Agreement”), pursuant to which the Company granted to Rosen a senior security interest in substantially all of the Company’s assets as security for repayment of the May 2016 Rosen Loan. Pursuant to the May 2016 Rosen Loan Agreement, the May 2016 Rosen Loan bears interest at a rate of 12.5% per annum, compounded annually and payable on the maturity date of May 26, 2017 (the “May 2016 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the May 2016 Rosen Loan are due. The Company entered into an amendment to the May 2016 Rosen Loan extending the May 2016 Rosen Maturity Date to November 26, 2017. As additional consideration for entering in the May 2016 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 1,000,000 shares of the Company’s common stock at a purchase price of $0.40 per share (the “May 2016 Rosen Warrant”). The May 2016 Rosen Warrant contains anti-dilution provisions as further described therein. On September 7, 2017 (the “Conversion Date”), Rosen converted all accrued but unpaid interest on the May 2016 Rosen Loan from May 26, 2016 through September 6, 2017 in the amount of $150,128$124,306 (the “May 2016 Rosen Loan Interest”) into the Company’s August Convertible Note Offering, after which May 2016 Rosen Loan Interest was deemed paid in full through the Conversion Date. As of the date of this filing this note is in default.

25

The September 2017 Rosen Loan Agreement

On September 8, 2017,March 29, 2019, the Company entered into a loanan agreement (the “September 2017 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $224,000 (the “September 2017 Rosen Note”). The September 2017 Rosen Note is secured by an officer of the Company. As additional consideration for entering in the September 2017 Rosen Note Loan Agreement, the Company issued Rosen a five-year warrant to purchase 25,000 shares of the Company’s common stock at a purchase price of $0.20 per share. On November 13, 2017, in consideration for extending the September 2017 Rosen Note, Rosen was issued a warrant to purchase 100,000 shares of the Company’s common stock exercisable within five (5) years and with an exercise price of $0.20 per share.

On February 20, 2018, the Company entered into a forbearance agreement whereby the Company issued Rosen a five-year warrant to purchase 448,000 shares of the Company’s common stock at a purchase price of $0.20 per share. These warrants had a fair value of $65,378 which was recorded to Loss on extinguishment of debt. The new maturity date of the September 2017 Rosen Loan Agreement is September 8, 2018.

During the nine months ended September 30, 2018, the Company converted $224,000 of principal and $20,496 of unpaid interest into the August 2018 Equity Raise (as defined below).

The November 2017 Schiller Loan Agreement

On November 20, 2017, the Company entered into a loan agreement (the “November 2017 Schiller Loan Agreement”) with Mr. Len Schiller (“Schiller”), a member of the Company’s Board of Directors, whereby the Company issued Schiller a promissory note in the principal amount of $25,000 (the “November 2017 Schiller Note”). PursuantRosen to the November 2017 Schiller Loan Agreement, the November 2017 Schiller Note bears interest at a rate of 15% per annum. During the nine months ended September 30, 2018 the Company repaid $25,000 in principal and $637 in interest. 

The January 2018 Rosen Loan Agreement

On January 16, 2018, the Company entered into a loan agreement (the “January 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $60,000 (the “January 2018 Rosen Note”). The January 2018 Rosen Note is secured by an officer of the Company whereas upon default an officer of the Company owes default shares of the Company’s common stock to Rosen equal to the amount of principal outstanding divided by 0.20. Pursuant to the January 2018 Rosen Loan Agreement, the January 2018 Rosen Note bears interest at a rate of 6% per annum and is payable onfurther extend the maturity date of January 31, 2018 (the “January 2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under thethis loan to May 2016 Rosen Loan are due. During the nine months ended September 30, 2018, the Company repaid $60,000 in principal and $200 in interest. 15, 2019.

 

The January 2018 Gordon Loan Agreement

On January 16, 2018, the Company entered into a loan agreement (the “January 2018 Gordon Loan Agreement”) with Mr. Christopher Gordon (“Gordon”), whereby the Company issued Gordon a promissory note in the principal amount of $40,000 (the “January 2018 Gordon Note”). The January 2018 Gordon Note is secured by an officer of the Company whereas upon default an officer of the Company owes default shares of the Company’s common stock to Gordon equal to the amount of principal outstanding divided by 0.20. Pursuant to the January 2018 Gordon Loan Agreement, the January 2018 Gordon Note bears interest at a rate of 6% per annum and payable on the maturity date of January 31, 2018 (the “January 2018 Gordon Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the January 2018 Gordon Note are due. During the nine months ended September 30, 2018, the Company repaid $40,000 in principal and $105 in interest.


The First March 2018 Rosen Loan Agreement

On March 4, 2018, the Company entered into a loan agreement (the “First March 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $10,000 (the “First March 2018 Rosen Note”). As additional consideration for entering in the First March 2018 Rosen Note Loan Agreement, the Company issued Rosen a five-year warrant to purchase 10,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the First March 2018 Rosen Loan Agreement, the First March 2018 Rosen Note bears interest at a rate of 12% per annum and is payable on the maturity date of March 19, 2018 (the “First March 2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the First March 2018 Rosen Note was due. During the nine months ended September 30, 2018, the Company repaid $10,000 in principal and $260 in interest.

The Second March 2018 Rosen Loan Agreement

On March 9, 2018, the Company entered into a loan agreement (the “Second March 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $15,000 (the “Second March 2018 Rosen Note”). As additional consideration for entering in the Second March 2018 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 15,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the Second March 2018 Rosen Loan Agreement, the Second March 2018 Rosen Note bears interest at a rate of 12% per annum and is payable on the maturity date of March 24, 2018 (the “Second March 2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the Second March 2018 Rosen Note was due. During the nine months ended September 30, 2018, the Company repaid $15,000 in principal and $365 in interest.

The Third March 2018 Rosen Loan Agreement

On March 13, 2018, the Company entered into a loan agreement (the “Third March 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $10,000 (the “Third March 2018 Rosen Note”). As additional consideration for entering in the Third March 2018 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 10,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the Third March 2018 Rosen Loan Agreement, the Third March 2018 Rosen Note bears interest at a rate of 12% per annum and is payable on the maturity date of March 28, 2018 (the “Third March 2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the Third March 2018 Rosen Note was due. During the nine months ended September 30, 2018, the Company repaid $10,000 in principal and $230 in interest.

The May 2018 Schiller Loan Agreement

On May 2, 2018, the Company entered into a loan agreement (the “May 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the Company issued Schiller a promissory note in the principal amount of $100,000 (the “May 2018 Schiller Note”). As additional consideration for entering in the May 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase 300,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the May 2018 Schiller Loan Agreement, the May 2018 Schiller Note bears interest at a rate of 13% per annum and is payable on the maturity date of February 02, 2019 (the “May 2018 Schiller Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due under the May 2018 Schiller Loan.

During the nine months ended September 30, 2018, the Company converted $100,000 of principal and $4,369 of unpaid interest into the August 2018 Equity Raise (as defined below). 


The June 2018 Frommer Loan Agreement

 

On June 29, 2018, the Company entered into a loan agreement (the “June 2018 Frommer Loan Agreement”) with Jeremy Frommer, an officer of the Company, whereby the Company issued Frommer a promissory note in the principal amount of $10,000 (the “June 2018 Frommer Note”). As additional consideration for entering in the June 2018 Frommer Note Loan Agreement, the Company issued Frommer a four-year warrant to purchase 30,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the June 2018 Frommer Loan Agreement, the June 2018 Frommer Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 (the “June 2018 Frommer Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due under the June 2018 Frommer Loan.  Subsequent to the balance sheet date, on. On November 8, 2018 the Company executed upon an agreement that extended the maturity date of this loanthe June 2018 Frommer Agreement to March 7, 2019. As part of the extension agreement, the Company issued Frommer an additional 40,854 warrants to purchase common stock of the Company at an exercise price of $0.30. These warrants had a fair value of $4,645 which was recorded to loss on extinguishment of debt. On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the June 2018 Frommer Agreement to March 7, 2019. As part of the extension agreement, the Company issued Frommer an additional 41,534 warrants to purchase common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Frommer that further extended the maturity date of this loan to May 15, 2019. 

 

The First July 2018 Schiller Loan Agreement

 

On July 3, 2018, the Company entered into a loan agreement (the “First July 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the Company issued Schiller a promissory note in the principal aggregate amount of $35,000 (the “First July 2018 Schiller Note”). As additional consideration for entering in the First July 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase 75,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the agreement, the note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which time all outstanding principal, accrued and unpaid interest were due under the First July 2018 Schiller Loan.2018.  Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an agreement that extended the maturity date of this loan to March 7, 2019. As part of the extension agreement, the Company issued Schiller warrants to purchase 142,987 shares of common stock of the Company at an exercise price of $0.30. On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the First July 2018 Schiller Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Schiller an additional 64,077 warrants to purchase common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Schiller that extended the maturity date of this loan to May 15, 2019.


The Second July 2018 Schiller Loan Agreement

 

On July 17, 2018, the Company entered into a loan agreement (the “Second July 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the Company issued Schiller a promissory note in the principal aggregate amount of $25,000 (the “Second July 2018 Schiller Note”). As additional consideration for entering in the Second July 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase 75,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the Second July 2018 Schiller Loan Agreement, the Second July 2018 Schiller Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which time all outstanding principal, accrued and unpaid interest were due under the Second July 2018 Schiller Loan.2018. Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an agreement that extended the maturity date of this loan to March 7, 2019. As part of the extension agreement, the Company issued Schiller warrants to purchase 101,900 shares of common stock of the Company at an exercise price of $0.30. On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the Second July 2018 Schiller Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Schiller an additional 103,600 warrants to purchase common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Schiller that further extended the maturity date of this loan to May 15, 2019.

 

The First July 2018 Rosen Loan Agreements

 

On July 12, 2018, the Company entered into a loan agreement (the “First July 2018 Rosen Loan Agreement”) with Rosen, an officer of the Company, whereby the Company issued Rosen a promissory note in the principal aggregate amount of $10,000 (the “First July 2018 Rosen Note”). Pursuant to the First July 2018 Rosen Loan Agreement, the note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which time all outstanding principal, accrued and unpaid interest are due under the First July 2018 Rosen Note. Subsequent to the balance sheet date, on2018. On November 8, 2018 the Company executed upon an agreement that extended the maturity date of this loan to March 7, 2019. As part of the extension agreement, the Company issued Rosen warrants to purchase 27,534 shares of common stock of the Company at an exercise price of $0.30. On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the First July 2018 Rosen Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Rosen an additional 207,400 warrants to purchase common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Rosen that further extended the maturity date of this loan to May 15, 2019.

 

The Second July 2018 Rosen Loan Agreements

 

On July 18, 2018, the Company entered into a loan agreement (the “Second July 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal aggregate amount of $50,000 (the “Second July 2018 Rosen Note”) resulting from the conversion of a demand note.note (as described below). As additional consideration for entering into the Second July 2018 Rosen Loan Agreement, the Company issued Rosen a four-year warrant to purchase 150,000 shares of the Company’s common stock at a purchase price of $0.20 per share. Pursuant to the Second July 2018 Rosen Loan Agreement, the Second July 2018 Rosen Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which time all outstanding principal, accrued and unpaid interest are due under the Second July 2018 Rosen Note. Subsequent to the balance sheet date, on2018. On November 8, 2018 the Company executed upon an agreement that extended the maturity date of this loan to March 7, 2019. As part of the extension agreement, the Company issued Rosen warrants to purchase 203,967 shares of common stock of the Company at an exercise price of $0.30. On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the Second July 2018 Rosen Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Rosen an additional 41,440 warrants to purchase common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Rosen that further extended the maturity date of this loan to May 15, 2019.

 

Line of credit – related partyThe December 2018 Rosen Loan Agreement

 

On May 9, 2017,December 27, 2018, the Company entered into a Revolving Line of Creditloan agreement (the “Grawin LOC”“December 2018 Rosen Loan Agreement”) with Grawin, LLC, a limited liability company controlled byRosen, whereby the Company issued Rosen a related party. The Grawin LOC was establishedpromissory note in the principal amount of $75,000 (the “December 2018 Rosen Note”). As additional consideration for a period of twelve months, with a maturity date of Mayentering in the December 2018 in whichRosen Note Loan Agreement, the Company can borrow principal upissued Rosen a four-year warrant to $130,000. The Grawin LOCpurchase 75,000 shares of the Company’s common stock at a purchase price of $0.30 per share. Pursuant to the December 2018 Rosen Loan Agreement, the December 2018 Rosen Note bears interest at a rate of 18%6% per annum and payable on the maturity date of January 26, 2019 (the “December 2018 Rosen Maturity Date”). On June 8,February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the December 2018 Rosen Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Rosen an additional 703,889 warrants to purchase common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Rosen that extended the maturity date of this loan to May 15, 2019.


The December 2018 Gravitas Capital Loan Agreement

On December 27, 2018, the Grawin LOC’sCompany entered into a loan agreement (the “December 2018 Gravitas Capital Loan Agreement”) with Gravitas Capital, whereby the Company issued Gravitas Capital a promissory note in the principal amount of $50,000 (the “December 2018 Gravitas Capital Note”). As additional consideration for entering in the December 2018 Gravitas Capital Note Loan Agreement, the Company issued Gravitas Capital a four-year warrant to purchase 50,000 shares of the Company’s common stock at a purchase price of $0.30 per share. Pursuant to the December 2018 Gravitas Capital Loan Agreement, the December 2018 Gravitas Capital Note bears interest at a rate of 6% per annum and payable on the maturity date was extended to June 1, 2019.of January 27, 2019  (the “December 2018 Gravitas Capital Maturity Date”).

 

During the ninethree months ended SeptemberMarch 31, 2019 the Company repaid $50,000 in principal and $250 in interest.

The January 2019 Rosen Loan Agreement

On January 30, 2019, the Company entered into a loan agreement (the “January 2019 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $175,000 (the “January 2019 Rosen Note”). As additional consideration for entering in the January 2019 Rosen Note Loan Agreement, the Company issued Rosen a four-year warrant to purchase 300,000 shares of the Company’s common stock at a purchase price of $0.30 per share. Pursuant to the January 2019 Rosen Loan Agreement, the January 2019 Rosen Note bears interest at a rate of 10% per annum and payable on the maturity date of February 15, 2019 (the “January 2019 Rosen Maturity Date”). On February 19, 2018 the Company converted $130,000executed upon an agreement that extended the maturity date of this loan to March 7, 2019. As part of the extension agreement, the Company issued Rosen warrants to purchase 703,889 shares of common stock of the Company at an exercise price of $0.30. On March 29, 2019 the Company entered into an agreement with Mr. Rosen that extended the maturity date of this loan to May 15, 2019.

The February 2019 Gravitas Capital Loan Agreement

On February 6, 2019, the Company entered into a loan agreement (the “February 2019 Gravitas Capital Loan Agreement”) with Gravitas Capital, whereby the Company issued Gravitas Capital a promissory note in the principal amount of $75,000 (the “February 2019 Gravitas Capital Note”). As additional consideration for entering in the February 2019 Gravitas Capital Note Loan Agreement, the Company issued Gravitas Capital a four-year warrant to purchase 7,500 shares of the Company’s common stock at a purchase price of $0.30 per share. Pursuant to the February 2019 Gravitas Capital Loan Agreement, the February 2019 Gravitas Capital Note bears interest at a rate of 5% per annum and payable on the maturity date of February 28, 2019  (the “February 2019 Gravitas Capital Maturity Date”).

During the three months ended March 31, 2019 the Company repaid $75,000 in principal and $30,626 of unpaid interest into the August 2018 Equity Raise (as defined below). $3,500 in interest.

 

The February 2019 Rosen Loan Agreement

On February 14, 2019, the Company entered into a loan agreement (the “February 2019 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note in the principal amount of $50,000 (the “February 2019 Rosen Note”). As additional consideration for entering in the February 2019 Rosen Note Loan Agreement, the Company issued Rosen a four-year warrant to purchase 100,000 shares of the Company’s common stock at a purchase price of $0.30 per share. Pursuant to the February 2019 Rosen Loan Agreement, the February 2019 Rosen Note bears interest at a rate of 10% per annum and payable on the maturity date of February 28, 2019 (the “February 2019 Rosen Maturity Date”). On March 29, 2019 the Company entered into an agreement with Mr. Rosen that extended the maturity date of this loan to May 15, 2019.  

The March 2019 Gravitas Capital Loan Agreement

On March 11, 2019, the Company entered into a loan agreement (the “March 2019 Gravitas Capital Loan Agreement”) with Gravitas Capital, whereby the Company issued Gravitas Capital a promissory note in the principal amount of $80,000 (the “March 2019 Gravitas Capital Note”). As additional consideration for entering in the March 2019 Gravitas Capital Note Loan Agreement, the Company issued Gravitas Capital a four-year warrant to purchase 7,500 shares of the Company’s common stock at a purchase price of $0.30 per share. Pursuant to the March 2019 Gravitas Capital Loan Agreement, the March 2019 Gravitas Capital Note bears interest at a rate of 6% per annum and payable on the maturity date of April 11, 2019  (the “March 2019 Gravitas Capital Maturity Date”). On April 12, 2019 the Company executed upon an agreement that further extended the maturity date of the March 2019 Gravitas Capital Loan Agreement to May 15, 2019. As part of the extension agreement, the Company issued Gravitas Capital an additional 10,000 warrants to purchase common stock of the Company at an exercise price of $0.30.


Demand loan

 

On June 6, 2018, the Company’s related partyMarch 29, 2019, Standish made non-interest bearing loans of $50,000$300,000 to the Company in the form of cash. The loan is due on demand and unsecured. On July 12, 2018, this note was converted into The Second July 2018 Rosen Loan Agreements.


Note 9 – Capital Leases Payable

 

Capital lease obligation consistedOfficer compensation

During the three months ended March 31, 2019 the Company paid $25,952 for living expenses for officers of the following:Company.

    September 30,
2018
  December 31,
2017
 
         
(i) Capital lease obligation to a financing company for a term of five (5) years, collateralized by equipment, with interest at 10.0% per annum, with principal and interest due and payable in monthly installments of $383.10 $4,732  $4,732 
           
  Less current maturities  (4,732)  (4,732)
           
  Capital lease obligation, net of current maturities  -   - 
           
  Total Capital Lease Obligation $4,732  $4,732 
           
The capital leases mature as follows:
           
2018: $4,732  $4,732 

 

Note 10 –7 - Stockholders’ Deficit

 

Shares Authorized

 

Upon incorporation, the total number of shares of all classes of stock which the Company is authorized to issue is Three Hundred Twenty Million (320,000,000) shares of which Three Hundred Million (300,000,000) shares shall be Common Stock, par value $0.001 per share and Twenty Million (20,000,000) shall be Preferred Stock, par value $0.001 per share. The designations, rights, and preferences of such preferred stock are to be determined by the Board of Directors. 

 

Preferred Stock

Series A Cumulative Convertible Preferred Stock

On February 13, 2015, 100,000 shares of preferred stock were designated as Series A Cumulative Convertible Preferred Stock (“Series A”). Each share of Series A shall have a stated value equal to $100 (as adjusted for any stock dividends, combinations or splits with respect to such shares) (the “Series A Stated Value”).

The holders of the Series A shall be entitled to receive preferential dividends at the rate of 6% per share per annum on the Series A Stated Value, but before any dividend or other distribution will be paid or declared and set apart for payment on any shares of any Junior Stock, as defined. Such dividends shall compound annually and be fully cumulative, and shall accumulate from the date of original issuance of the Series A and shall be payable quarterly, in arrears, commencing on the first day of the calendar quarter following the date on which the Series A is issued. Upon the occurrence of an Event of Default (as defined below) and while such Event of Default is outstanding, such dividend rate shall be increased to 15% per annum on the Series A Stated Value. At the Company’s option, such dividend payments may be made in (i) cash (ii) additional shares of Series A valued at the Series A Stated Value thereof, in an amount equal to 150% of the cash dividend otherwise payable or (iii) a combination of cash and additional shares of Series A, provided there is not an existing current Event of Default on the date on which a dividend payment is payable, in which event the Holder entitled to receive such dividend may elect to receive such dividends in cash or additional shares of Series A Preferred.


The dividends on the Series A shall be cumulative whether or not declared so that, if at any time full cumulative dividends at the rate aforesaid on all shares of the Series A then outstanding from the date from and after which dividends thereon are cumulative to the end of the annual dividend period next preceding such time shall not have been paid or declared and set apart for payment, or if the full dividend on all such outstanding Series A for the then current dividend period shall not have been paid or declared and set apart for payment, the amount of the deficiency shall be paid or declared and set apart for payment before any sum shall be set apart for or applied by the Corporation or a subsidiary of the Corporation to the purchase, redemption or other acquisition of the Series A or any shares of any other class of stock ranking on a parity with the Series A and before any dividend or other distribution shall be paid or declared and set apart for payment on any Junior Stock and before any sum shall be set aside for or applied to the purchase, redemption or other acquisition of any Junior Stock.

Holder of Series A shall have the right at any time after the issuance, to convert such shares, accrued but unpaid declared dividends on the Series A and any other sum owed by the Corporation arising from the Series A into fully paid and non-assessable shares of Common Stock (the “Conversion Shares”) of the Corporation determined in accordance with the applicable conversion price (the “Conversion Price”). 

The number of Conversion Shares issuable upon conversion shall equal (i) the sum of (A) the Series A Stated Value being converted and/or (B) at the Holder’s election, accrued and unpaid dividends or any other component of the Conversion Amount, divided by (ii) the Conversion Price. The Conversion Price of the Series A shall be $0.25, subject to adjustment.

During the year ended December 31, 2016 the conversion price was adjusted to $0.164

The Corporation and the Holder may not convert that amount of the Conversion Amount on a Conversion Date in amounts that would result in the Holder having a beneficial ownership of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially owned by the Holder and its Affiliates on such Conversion Date, and (ii) the number of Conversion Shares issuable upon the conversion of the Conversion Amount with respect to which the determination of this provision is being made on such Conversion Date, which would result in the aggregate beneficial ownership by the Holder and its Affiliates of more than 4.99% of the outstanding shares of Common Stock of the Corporation. For the purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the 1934 Act and Regulation 13d-3 thereunder. Subject to the foregoing, the Holder shall not be limited to successive exercises which would result in the aggregate issuance of more than 4.99%. The Holder may allocate which of the equity of the Corporation deemed beneficially owned by the Holder shall be included in the 4.99% amount described above and which shall be allocated to the excess above 4.99%. The Holder may waive the conversion limitation described in this Section in whole or in part, upon and effective after sixty-one (61) days’ prior written notice to the Corporation. 

The holders of our Series A do vote together with the holders of our Common Stock on an as converted basis on each matter submitted to a vote of holders of Common Stock. The number of votes that may be cast by a holder of Series A shall be equal to the number of shares of Common Stock issuable upon conversion of such Holder’s Series A on the record date for determining those stockholders entitled to vote on the matter. In addition, the affirmative vote of the holders of a majority of our outstanding Series A is required to for the following actions:

(a) amending the Corporation’s certificate of incorporation or by-laws if such amendment would adversely affect the Series A

(b) purchasing any of the Corporation’s securities other than required redemptions of Series A and repurchase under restricted stock and option agreements authorizing the Corporation’s employees;

(c) effecting a Liquidation Event;

(d) declaring or paying any dividends other than in respect of the Series A; and

(e) issuing any additional securities having rights senior to or on parity with the Series A.

As of September 30,March 31, 2019, and December 31, 2018 the Company has undeclared Series A dividends of $0.

See below for discussion of conversion of Series A in relation to the private placement closing in August 2018.


Series B Cumulative Convertible Preferred Stock

On December 21, 2015, 20,000 shares ofthere were no preferred stock were designated as Series B Cumulative Convertible Preferred Stock (“Series B”). Each share of Series B shall have a stated value equal to $100.00 (as adjusted for any stock dividends, combinationsissued or splits with respect to such shares) (the “Series B Stated Value”).

The holders of outstanding shares of Series B shall be entitled to receive preferential dividends at the rate of 6% per share per annum on the Series B Stated Value, but before any dividend or other distribution will be paid or declared and set apart for payment on any shares of any Junior Stock as defined. Such dividends shall compound annually and be fully cumulative and shall accumulate from the date of original issuance of the Series B, and shall be payable quarterly, in arrears, commencing on the first day of the calendar quarter following the date on which the Series B is issued. Upon the occurrence of an Event of Default as defined below and while such Event of Default is outstanding, such dividend rate shall be increased to 15% per annum on the Series B Stated Value. At the Corporation’s option, such dividend payments may be made in (i) cash (ii) additional shares of Series B valued at the Series B Stated Value thereof, in an amount equal to 100% of the cash dividend otherwise payable or (iii) a combination of cash and additional shares of Series B, provided there is not an existing current Event of Default on the date on which a dividend payment is payable, in which event the Holder entitled to receive such dividend may elect to receive such dividends in cash or additional shares of Series B Preferred.

The dividends on the Series B shall be cumulative whether or not declared so that, if at any time full cumulative dividends at the rate aforesaid on all shares of the Series B then outstanding from the date from and after which dividends thereon are cumulative to the end of the annual dividend period next preceding such time shall not have been paid or declared and set apart for payment, or if the full dividend on all such outstanding Series B for the then current dividend period shall not have been paid or declared and set apart for payment, the amount of the deficiency shall be paid or declared and set apart for payment before any sum shall be set apart for or applied by the Corporation or a subsidiary of the Corporation to the purchase, redemption or other acquisition of the Series B or any shares of any other class of stock ranking on a parity with the Series B and before any dividend or other distribution shall be paid or declared and set apart for payment on any Junior Stock and before any sum shall be set aside for or applied to the purchase, redemption or other acquisition of any Junior Stock.

Holders of shares of Series B shall have the right at any time commencing after the issuance to convert such shares, accrued but unpaid declared dividends on the Series B into fully paid and non-assessable shares of Common Stock (the “Conversion Shares”) of the Corporation determined in accordance with the applicable conversion price (the “Conversion Price”). All declared or accrued but unpaid dividends may be converted at the election of the Holder together with or independent of the conversion of the Series B Stated Value of the Series B.  

The number of Conversion Shares issuable upon conversion of the Conversion Amount shall equal (i) the sum of (A) the Series B Stated Value being converted and/or (B) at the Holder’s election, accrued and unpaid dividends or any other component of the Conversion Amount, divided by (ii) the Conversion Price. The Conversion Price of the Series B shall be $0.30, subject to adjustment.

During the year ended December 31, 2016 the conversion price was adjusted to $0.197.

The Corporation and the Holder may not convert that amount of the Conversion Amount on a Conversion Date in amounts that would result in the Holder having a beneficial ownership of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially owned by the Holder and its Affiliates on such Conversion Date, and (ii) the number of Conversion Shares issuable upon the conversion of the Conversion Amount with respect to which the determination of this proviso is being made on such Conversion Date, which would result in the aggregate beneficial ownership by the Holder and its Affiliates of more than 4.99% of the outstanding shares of Common Stock of the Corporation. For the purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the 1934 Act and Regulation 13d-3 thereunder. Subject to the foregoing, the Holder shall not be limited to successive exercises which would result in the aggregate issuance of more than 4.99%. The Holder may allocate which of the equity of the Corporation deemed beneficially owned by the Holder shall be included in the 4.99% amount described above and which shall be allocated to the excess above 4.99%. The Holder may waive the conversion limitation described in this Section in whole or in part, upon and effective after sixty-one (61) days’ prior written notice to the Corporation.

The holders of our Series B do vote together with the holders of our Common Stock on an as converted basis on each matter submitted to a vote of holders of Common Stock. The number of votes that may be cast by a holder of Series B shall be equal to the number of shares of Common Stock issuable upon conversion of such Holder’s Series B on the record date for determining those stockholders entitled to vote on the matter. In addition, the affirmative vote of the holders of a majority of our outstanding Series B is required to for the following actions:

(a) amending the Corporation’s certificate of incorporation or by-laws if such amendment would adversely affect the Series B

(b) purchasing any of the Corporation’s securities other than required redemptions of Series B and repurchase under restricted stock and option agreements authorizing the Corporation’s employees;

(c) effecting a Liquidation Event;

(d) declaring or paying any dividends other than in respect of the Company’s Series A or Series B; and

(e) issuing any additional securities having rights senior to the Series B. 

As of September 30, 2018, the Company has undeclared Series B dividends of $0.

See below for discussion of conversion of Series B in relation to the private placement closing in August 2018.


Series D Convertible Preferred Stock

On January 29, 2016, 2,100,000 shares of preferred stock were designated as Series D Convertible Preferred Stock (“Series D”). Each share of Series A shall have a stated value equal to $100.00 (as adjusted for any stock dividends, combinations or splits with respect to such shares) (the “Series D Stated Value”).

Holders of shares of Series D shall have the right at any time commencing after the issuance to convert such shares into fully paid and non-assessable shares of Common Stock (the “Conversion Shares”) of the Corporation determined in accordance with the applicable conversion price (the “Conversion Price”).

The number of Conversion Shares issuable upon conversion of the Conversion Amount shall equal (i) the sum of (A) the Series D Stated Value being converted and/or (B) at the Holder’s election, accrued and unpaid dividends or any other component of the Conversion Amount, divided by (ii) the Conversion Price. The Conversion Price of the Series D is $0.25, subject to adjustment.

The Company and the Holder may not convert that amount of the Conversion Amount on a Conversion Date in amounts that would result in the Holder having a beneficial ownership of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially owned by the Holder and its Affiliates on such Conversion Date, and (ii) the number of Conversion Shares issuable upon the conversion of the Conversion Amount with respect to which the determination of this proviso is being made on such Conversion Date, which would result in the aggregate beneficial ownership by the Holder and its Affiliates of more than 4.99% of the outstanding shares of Common Stock of the Corporation. For the purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the 1934 Act and Regulation 13d-3 thereunder. Subject to the foregoing, the Holder shall not be limited to successive exercises which would result in the aggregate issuance of more than 4.99%. The Holder may allocate which of the equity of the Corporation deemed beneficially owned by the Holder shall be included in the 4.99% amount described above and which shall be allocated to the excess above 4.99%. The Holder may waive the conversion limitation described in this Section in whole or in part, upon and effective after sixty one (61) days’ prior written notice to the Corporation.

The holders of Series D Preferred shall not be entitled to a vote on matters submitted to a vote of the stockholders of the Company. Also, as long as any shares of Series D Preferred are outstanding, the Company shall not, without the affirmative vote of all of the Holders of the then outstanding shares of the Series D Preferred,

(a) alter or change adversely the powers, preferences or rights given to the Series D Preferred or alter or amend this Certificate of Designation,

(b) amend its articles of incorporation or other charter documents in any manner that adversely affects any rights of the Holders,

(c) increase the number of authorized shares of Series D Preferred, or

(d) enter into any agreement with respect to any of the foregoing.outstanding.

 

Common Stock

 

On January 31, 2018,4, 2017, the Company issued 18,750 shares of its restricted common stock to settle outstanding vendor liabilities of $3,750. In connection with this transaction the Company also recorded a gain on settlement of vendor liabilities of $375. 

During the nine months ended September 30, 2018, the Company issued 610,0002,000,000 shares of its restricted common stock to consultants in exchange for services at a fair value of $116,300. These$240,000.

On January 3, 2017, the Company issued 500,000 shares were recorded asof its restricted common stock issuedto consultants in exchange for prepaid services and will be expensed over the lifeat a fair value of the consulting contract to share based payments. During the nine months ended September 30, 2018 the Company recorded $72,835 to share based payments.$70,050.

 

August 2018 Equity Raise

 

Effective August 31, 2018 (the “Effective Date”), the Company consummated the initial closing (the “Initial Closing”) of a private placement offering of its securities of up to $5,000,000 (the “August 2018 Equity Raise”).In connection withDuring the Initial Closing,three months ended March 31, 2019 the Company entered into definitive securities purchase agreements (the “Purchase Agreements”) with 37 accredited investors (the “Purchasers”) for aggregate gross proceeds of $1,155,832$649,829. Pursuant to the Purchase Agreement, the Purchasers purchased an aggregate of 4,623,3282,599,320 shares of common stock at $0.25 per share and received warrants to purchase 4,623,3282,599,320 shares of common stock at an exercise price of $0.30 per share (the “Purchaser Warrants”, collectively, the “Securities”). Further, pursuant to the Purchase Agreements, the Company expects to have two additional closings within the next 180 days and has already received commitments for an additional $2,022,996 in capital, bringing the total dollar amount committed to the Offering in excess of $3,000,000. Additionally, the Purchasers may participate in a subsequent offering of the Company’s securities in an aggregate amount of up to 50% of the subsequent offering on the twenty-four (24) month anniversary of the close of the Third Closing (as defined in the Securities Purchase Agreement) of the Private Offering. Investors have deposited $208,428 for future closings of the August 2018 Equity Raise. This amount has been recorded as a liability on the balance sheet.

 

The Purchaser Warrants are exercisable for a term of five years from the Initial Exercise Date (as defined in the Purchaser Warrants).

In connection with the August 2018 Equity Raise, the Company will issue 2,200,000 shares of Common Stock, will pay fees of $135,825 and will grant warrants to purchase 81,584 shares of common stock at an exercise price of $0.30 per share for services rendered as the Company’s placement agent in the Private Offering. The company has recorded $375,082 to stock issuances costs, and is part of Additional Paid-in Capital.


Letter Agreements for the Conversion of Debt and Preferred Stock

In connection with the August 2018 Equity Raise, the Company entered into those certain letter agreements (the “Debt Conversion Agreements”) with certain holders of its debt securities (the “Debt Holders”), for the conversion of an aggregate amount of $7,992,570 of principal and $1,028,772 of accrued but unpaid interest of the Company’s debt obligations into 45,106,731 shares of Common Stock at a conversion price equal to $0.20 per share. Additionally, as inducement to enter into the Debt Conversion Agreement, the Debt Holders were issued warrants to purchase 22,553,390 shares of Common Stock at an exercise price equal to $0.30 per share, expiring five years from the date of issuance (the “Incentive Debt Warrants”). The Company recorded a Loss on extinguishment of debt of $2,914,917 in connection with of the debt conversions. See Notes 6, 7 and 8.

Concurrently with its entrance in the Debt Conversion Agreements, the Company entered into those letter agreements (the “Preferred Stock Conversion Agreements”) with certain holders (the “Preferred Holders”) of its Series A Cumulative Convertible Preferred Stock and Series B Cumulative Convertible Preferred Stock (the “collectively, the Preferred Stock”) whereby the Preferred Holders converted 38,512 shares of the Preferred Stock into an aggregate of 26,866,582.00 shares of Common Stock at conversion prices equal to $0.19683 per share for Series A and $0.164 per share for Series B. As in an inducement to enter into the Preferred Stock Conversion Agreements, the Preferred Holders were issued warrants to purchase 13,433,305 shares of Common Stock at an exercise price equal to $0.30 per share, expiring five years from the date of issuance (the “Incentive Preferred Warrants”, and together with the Incentive Debt Warrants, the “Incentive Warrants”). The Company recorded an inducement of $2,016,634 in connection with of the Preferred conversionsand is recorded as an adjustment to net loss attributable to common shareholders, on the statements of operations.

Stock Options

The Company applied fair value accounting for all share-based payments awards. The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model. 

At September 30, 2018 and 2017, the aggregate intrinsic value of options outstanding and exercisable was $1,000 and $1,000, respectively. 

Stock-based compensation for stock options has been recorded in the consolidated statements of operations and totaled $ 261,837.99 and $560,794, for the nine months ended September 30, 2018 and 2017, respectively.

The Company did not issue any new options during the nine months ended September 30, 2018.

 

Warrants

 

The Company applied fair value accounting for all share-based payments awards. The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model.


The assumptions used for warrants granted during the ninethree months ended September 30, 2018March 31, 2019 are as follows:

 

September 30,
2018
Exercise price$0.20-.030
Expected dividends0%
Expected volatility102% - 107%
Risk free interest rate2%-3%
Expected life of warrant4 - 5 years
  

March 31,

2019

  March 31,
2018
 
Exercise price $0.30  $0.20 
Expected dividends  0%  0%
Expected volatility  108.16%  93,69% - 100.56%
Risk free interest rate  2.23% - 2.5%  1.64% - 2.69%
Expected life of warrant  4 – 5 years   4 – 5 years 

 

33

 

Warrant Activities

 

The following is a summary of the Company’s warrant activity:

 

 Warrants  Weighted
Average
Exercise
Price
  Warrants  Weighted Average
Exercise
Price
 
          
Outstanding – December 31, 2017  46,193,779  $0.24 
Outstanding – December 31, 2018  110,859,062      0.27 
Granted  57,197,956   0.27   5,527,560   0.30 
Exercised  (50,000)  0.40   -   - 
Forfeited/Cancelled  -   -   (40,000)  0.30 
Outstanding and Exercisable – September 30, 2018  103,341,735  $0.26 
Outstanding and Exercisable – March 31, 2019  116,346,622  $0.27 

 

Warrants OutstandingWarrants Outstanding  Warrants Exercisable Warrants Outstanding  Warrants Exercisable
Exercise priceExercise price  Number
Outstanding
  Weighted Average
Remaining Contractual Life
(in years)
  Weighted
Average
Exercise Price
  Number
Exercisable
  Weighted
Average
Exercise Price
 Exercise price  Number
Outstanding
  Weighted Average
Remaining Contractual Life
(in years)
  Weighted
Average
Exercise Price
  Number
Exercisable
 Weighted
Average
Exercise Price
 
$0.26   103,341,735   4.01   0.26   103,341,735   0.26 0.27   116,346,622   3.63   0.27  116,346,622  0.27 

 

During the ninethree months ended September 30, 2018,March 31, 2019, a total of 2,758,833782,100 warrants were issued with promissoryconvertible notes (See Note 5 above). The warrants have a grant date fair value of $69,317 using a Black-Scholes option-pricing model and the above assumptions.

During the three months ended March 31, 2019, a total of 1,882,140 warrants were issued with notes payable – related party (See Note 6 above). The warrants have a grant date fair value of $478,064$104,900 using a Black-Scholes option-pricing model and the above assumptions.

 

During the ninethree months ended September 30, 2018,March 31, 2019, a total of 10,481,016 warrants were issued with convertible notes (See Note 7 above). The warrants have a grant date fair value of $1,284,683 using a Black-Scholes option-pricing model and the above assumptions.

During the nine months ended September 30, 2018, a total of 1,863,000 warrants were issued with notes payable – related party (See Note 8 above). The warrants have a grant date fair value of $358,030 using a Black-Scholes option-pricing model and the above assumptions.

During the nine months ended September 30, 2018, a total of 1,403,500264,000 warrants were issued with convertible notes payable – related party (See Note 86 above). The warrants have a grant date fair value of $162,834$12,027 using a Black-Scholes option-pricing model and the above assumptions. 

 

During the ninethree months ended September 30, 2018,March 31, 2019, a total of 40,691,6072,599,320 warrants were issued with the August 2018 Equity Raise (See above). The warrants have a grant date fair value of $5,741,297$334,985 using a Black-Scholes option-pricing model and the above assumptions.


Note 11 – Commitments and ContingenciesLeases

 

Lease Agreements

 

On May 5, 2018, the Company signed a 5-year lease for approximately 2,300 square feet of office space at 2050 Center Avenue suiteSuite 640, Fort lee,Lee, New Jersey 07024. Commencement date of the lease is June 1, 2018. Total amount due under this lease is $411,150.

 

We determine if an arrangement contains a lease at inception. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term.

Our leases consist of leaseholds on office space. The approach takes into consideration the range of the term, the range of the lease payments, the category of the underlying asset and our estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments.

Our lease term includes options to extend the lease when it is reasonably certain that we will exercise that option. Leases with a term of 12 months or less are not recorded on the balance sheet, per the election of the practical expedient noted above.

We recognize lease expense for these leases on a straight-line basis over the lease term. We recognize variable lease payments in the period in which the obligation for those payments is incurred. Variable lease payments that depend on an index or a rate are initially measured using the index or rate at the commencement date, otherwise variable lease payments are recognized in the period incurred.

During the three months ended March 31, 2019 the Company incurred $20,690 towards the amortization of assets included in general and administrative expenses on the Condensed Consolidated Statements of Operations.

Total future minimum payments required under the lease as of March 31, 2019 are as follows:

Twelve Months Ending March 31,   
2020 $76,973 
2021  80,944 
2022  85,034 
2023  91,336 
2024  15,410 
Total $349,697 

Rent expense for the three and nine months ended September 30,March 31, 2019 and 2018 was $20,557and $146,056 respectively,$20,690 and was $66,569 and $144,425, respectively, for the three and nine months ended September 30, 2017. 


Note 12 – Revision of Prior Year Financial Statements:$10,957 respectively. 

 

The Company’s correction of accrued dividends was a result of the following:

Management was accruing dividends as a liability, despite the fact the Board of Directors had not formally declared the dividends payable. This results in accrued dividends being removed from the liabilities section of the balance sheet,

Management was not compounding the dividends annually,

Management was not presenting the accrued dividends on the consolidated statement of operations, ultimately being included in the loss per share.

In accordance with the guidance provided by the SEC’s Staff Accounting Bulletin 99,Materiality and Staff Accounting Bulletin No. 108,Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements the Company has determined that the impact of adjustments relating to the correction of this accounting error are not material to previously issued consolidated financial statements. Accordingly, these changes are disclosed herein and will be disclosed prospectively.

As a result of the aforementioned correction of accounting errors, the relevant financial statements have been revised as follows:

Effects on respective financial statements are as noted below:

  December 31, 2017 
  As Previously Reported  Adjustment  As Revised 
Balance Sheet            
Current Liabilities            
Accrued dividends $472,444  $(472,444) $- 
Total Current Liabilities $4,159,644  $(472,444) $3,687,200 
Total Liabilities $8,017,183  $(472,444) $7,544,739 
             
Stockholders’ Equity            
Total Stockholders’ Equity $7,839,751  $(472,444) $7,367,307 

  For the nine months ended
September 30, 2017
 
  As Previously Reported after Adoption of ASU 2017-11  Adjustments  As Revised 
Statement of Operations            
Deemed dividend $-  $   $203,365 
Net loss attributable to common stockholders $(6,377,874) $(203,365) $(6,581,239)
Basic and diluted loss per share $(0.17) $    (0.17)
             
Statements of Cash Flows            
Supplementary Disclosure of Non-Cash Investing And Financing Activities            
Deemed dividend $-  $203,365  $203,365 

  For the three months ended
September 30, 2017
 
  As Previously Reported after Adoption of ASU 2017-11  Adjustments  As Revised 
Statement of Operations         
Deemed dividend $-  $   $74,014 
Net loss attributable to common stockholders $(3,421,965) $(74,014) $(3,495,979)
Basic and diluted loss per share $(0.09) $    (0.09)

Note 13 – Subsequent Events

 

Second ClosingClose of August 2018 Equity RaiseTender Offer

 

On or about October 30, 2018,April 11, 2019, the Company substantially completed its offer to holders of certain of the Company’s outstanding warrants. The aggregate amount of these warrants tendered, each with an exercise price of $0.20, represents approximately 91% of the warrants eligible to be exchanged in the tender offer, and 49% of the Company’s total outstanding warrants. The Company exchanged warrants to purchase approximately 56,571,598 shares of common stock as part of the tender offer. Participating investors received approximately 18,784,878 shares of common stock for returning the warrants.

Close of Convertible Note Offering

Between February 21, 2019 and February 26, 2019, and between March 12, 2019 and March 29, 2019, Jerrick Media Holdings, Inc. (the “Company”) consummated the second closinginitial closings (the “Second Closing”“Initial Closings”) of the August 2018 Equity Raise.a private placement offering of its securities of up to $3,000,000 (the “Offering”). In connection with the Second Closing,Initial Closings, the Company entered into definitive securities purchase agreements (the “Purchase Agreements)Agreements”) with an additional 912 accredited investors (the “Purchasers”“Initial Purchasers”) for an aggregate gross proceedspurchase price of $161,000.$1,092,500. Pursuant to the Purchase Agreements, the Initial Purchasers purchased an aggregate of 644,000 shares of common stock at $0.25 per share and received warrants to purchase 644,000 shares of common stock at an exercise price of $0.30 per share (the “Purchaser Warrants”, collectively, the “Securities”). More details regardingThe Initial Purchasers received 1,442,100 Purchaser Warrants.

On May 7, 2019, the Company consummated the final closing (the “Final Closing”) of a private placement offering of its securities of up to $3,000,000 (the “Offering”). In connection with the Final Closing, the Company will issue 1,231,593 warrants to purchase shares of common stock at an exercise price of $0.30 per share (the “Purchaser Warrants”) to 5 accredited investors (the “Final Closing Purchasers” and, together with the Initial Purchasers, “the Offering’s Purchasers”), for an aggregate purchase price of $933,025. This includes $162,500 in second tranche payments to be made by the Offering’s Purchasers, due when the Company meets certain performance criteria as outlined in the Purchase Agreements.

In connection with the Offering, the Company issued convertible notes (the “Notes”) in the principal aggregate amount of $1,863,025, with an additional $162,500 in Notes to be issued upon the achievement of certain milestones. The Notes accrue interest at a rate of 10% per annum and the interest is payable in kind upon the twelve (12) month anniversary of the Notes. The Notes have maturity dates between February 21, 2020 and May 7, 2020, respectively (the “Maturity Dates”). The Notes are convertible any time after their issuance. The Offering’s Purchasers have the right to convert the Notes into shares of the Company’s August 2018 Equity Raise may be foundcommon stock, par value $0.001 per share (“Common Stock”) at the lesser of (i) a fixed conversion price equal to $0.25 per share or (ii) the price provided to investors in connection with (a) any private placement offerings or one or more registered public offerings by the Company under the Securities Act, pursuant to which the Company receives monies in the amount greater than $1,500,000 in exchange for securities of the Company between February 21, 2019 and the date on which the Company’s Current Report on Form 8-K filedconsummates a listing onto a national securities exchange, or (b) any private placement offerings or one or more registered public offerings by the Company under the Securities Act in connection with the SEC on October 24, 2018.its listing onto a national securities exchange (a “Qualified Offering”).

 

In the event that the Offering’s Purchasers do not choose to convert the Notes into the Common Stock on or prior to the Maturity Dates, the principal and interest evidenced by the Note shall be mandatorily converted upon the earlier of (i) the listing of the Common Stock onto a national securities exchange, or (ii) upon a Qualified Offering.

The Purchaser Warrants are exercisable into a total of 2,673,693 shares of the Company’s common stock. The Purchaser Warrants issued in this transaction are immediately exercisable at an exercise price of $0.30 per share, subject to applicable adjustments. The Purchaser Warrants expire four (4) years from the original issue date.


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This quarterly report on Form 10-Q and other reports filed by Jerrick Media Holdings, Inc. (the “Company”) from time to time with the SEC (collectively, the “Filings”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks relating to the Company’s business, industry, and the Company’s operations and results of operations. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

 

Overview

 

We intend for this discussion to provide information that will assist in understanding our financial statements, the changes in certain key items in those financial statements, and the primary factors that accounted for those changes, as well as how certain accounting principles affect our financial statements. This discussion should be read in conjunction with our financial statements and accompanying notes for the nine monthsyear ended September 30,December 31, 2018, included in the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2019.

We intend for this discussion to provide information that will assist in understanding our financial statements, the changes in certain key items in those financial statements, and the primary factors that accounted for those changes, as well as how certain accounting principles affect our financial statements. This discussion should be read in conjunction with our financial statements and accompanying notes for the years ended December 31, 2018 and 2017, included elsewhere in this report.

 

The Company develops technology-based solutions designed to solve for challenges that have resulted from disruption within the broad digital media and content generation business environment. Jerrick’s flagship product Vocal is a long-form, digital publishing platform focused on supporting content creators with content management tools that are embedded within digital communities. Vocal is architected to enable targeted marketing of branded content and e-commerce opportunities in long-form content.

 

Vocal serves as a versatile home for content creators and brands. The platform supports multiple forms of content such as: short videos, podcasts, music, and written word. This pace of activity is expected to increase.

 


We partner with content creators and brands that recognize difficulties inherent in the digital advertising space and can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

 

During the remainder of the fourth quarter of 2018 and first half of Fiscal Year 2019, Jerrick plans to launch additional revenue lines, including brand subscriptions to access the platform and its community of creators as well as a subscription model for content creator upgrade tools. The Company also intends to release further enhancements to the Vocal editor and introduce additional social and user analytics features.Further, in 2019 the Company plans to introduce Software as a Service (SaaS) subscriptions to the Vocal platform.


Results of Operations

 

Liquidity and Capital Resources

 

The following table summarizes total current assets, liabilities and working capital at September 30, 2018March 31, 2019 compared to December 31, 2017:2018:

 

 September 30,
2018
  December 31,
2017
  Increase /
(Decrease)
  March 31,
2019
  December 31,
2018
  Increase /
(Decrease)
 
Current Assets $232,879  $112,376  $120,503  $270,273  $6,500  $263,773 
Current Liabilities  2,603,869   3,687,200   (1,083,331) $3,869,128  $2,569,584  $

1,299,544

 
Working Capital Deficit $(2,370,990) $(3,574,824) $1,203,834  $

(3,598,855

) $(2,563,084) $

(1,035,771

)

 

At September 30, 2018,March 31, 2019, we had a working capital deficit of $2,370,990$3,598,855 as compared to a working capital deficit of $3,574,824$2,563,084 at DecemberMarch 31, 2017, a decrease2019, an increase of $1,203,834.$1,035,771. The decreaseincrease is primarily attributable to thean increase in cashnotes payable and prepaid expensesthe current portion of operating lease payable. These were offset by an increase in cash and a decrease in accounts payable and other accrued expenses, demand loan, line of credit and notes payable. These changes were offset by an increase convertible notes current.liabilities.

 

Net Cash

 

Net cash used in operating activities for the ninethree months ended September 30,March 31, 2019 and 2018, was $1,461,053 and 2017, was $3,447,763 and $2,476,844$1,124,349, respectively. The net loss for the ninethree months ended September 30,March 31, 2019 and 2018 was $1,897,972 and 2017 was $10,052,160 and $6,377,874,$2,093,630, respectively. This change is primarily attributable to the net loss for the current period offset by share-based payments in the amount of $329,857$318,636 to employees and consultants for services rendered, the accretion of debt discount and debt issuance costs of $2,039,589$47,364 due to the incentives given with debentures, and a loss on extinguishment of debt of $3,370,505, and a loss on settlement of debt of $15,275 for the incentives given to amend or convert debt$77,514 in addition to a change in accounts payable and accrued expenses of $848,171.$21,482. These increases were offset by gain on settlement of vendor liabilities of $2,886 and a change in accounts receivable of $5,632$1,066 during the ninethree months ended September 30, 2018.March 31, 2019.

 

Net cash used in investing activities for the ninethree months ended September 30,March 31, 2019 and 2018 and 2017 was $24,084$2,801 and $0, respectively. This change is attributable to the cash paid for leasehold improvements.property and equipment.

 

Net cash provided by financing activities for the ninethree months ended September 30,March 31, 2019 and 2018 was $1,726,561 and 2017 was $3,547,074 and $2,397,028.$1,135,404. During the 20182019 period, the Company was predominantly financed by issuance of common stock, debt and related party notes of $1,155,832, $1,525,154$649,829, $887,813 and $315,000,$580,000, respectively to fund operations. In addition, the Company received $208,428 from investors for the second close of the August 2018 equity raise. These increases were offset by repayment of line of credit, notes and related party notes of $44,996, $214,939$62,508 and $163,305,$125,000, respectively. The Company also paid $166,761 and $35,115 for debt issuance and stock issuance costs during the nine months ended September 30, 2018.

 

Summary of Statements of Operations for the Three Months Ended September 30, 2018March 31, 2019 and 2017:2018:

 

  Three Months Ended 
  September 30,
2018
  September 30,
2017
 
Revenue $25,119  $11,244 
Operating expenses  (907,707)  (1,418,386)
Loss from operations  (882,588)  (1,407,142)
Other expenses  (4,664,704)  (2,014,823)
Net loss $(5,547,292) $3,421,965)
Loss per common share – basic and diluted $(0.12) $(0.09)

  Three Months Ended 
  March 31,
2019
  March 31,
2018
 
Revenue $34,334  $16,249 
Gross Margin $

34,334

  $16,249 
Operating Expenses $

1,739,328

  $1,339,826 
Loss from operations $

(1,704,994

) $(1,323,577)
Other Expenses $(179,447) $(770,053)
Net loss $

(1,884,441

) $(2,093,630)
Loss per common share – basic and diluted $(0.01) $(0.05)

Revenue

 

Revenue was $25,119$34,334 for the three months ended September 30, 2018,March 31, 2019, as compared to $11,244$16,249 for the comparable three months ended September 30, 2017,March 31, 2018, an increase of $13,875.$18,085. The increase in revenue is primarily attributable to the Company’s transitioning from legacy businesses to generating revenue throughdevelopment and growth of native advertising, branded marketing, and affiliate sales, resulting from the creation of genre specific, user generated content community websites. As partwebsites, as well as the addition of that transition, theconsulting services as a new revenue line item. The Company focused its efforts throughout 2018the three months ended March 31, 2019 on the development of its proprietary Vocal software platform to support the scalability of its business model.

 

Operating Expenses

 

Operating expenses for the three months ended September 30, 2018March 31, 2019 were $907,707$1,739,328 as compared to $1,418,386$1,339,826 for the three months ended September 30, 2017.March 31, 2018. The decreaseincrease of $510,679$399,502 in operating expenses is the result of a reduction in accounts payable and a decreasean increase in consulting fees,, partially offset by an increase in employee compensation. Research and Development, marketing, and content creation costs.

 

Loss from Operations

 

Loss from operations for the three months ended September 30, 2018March 31, 2019 was $882,588$1,704,994 as compared to loss of $1,407,142$1,323,577 for the three months ended September 30, 2017.March 31, 2018. The decreaseincrease in the loss from operations is partially attributableprimarily due to increased expenses due to the continued development of the Vocal platform and increased marketing costs. These increases were offset by an increase in revenue but primarily due to a company-wide effort to reduce operating expenses while creating efficiencies in the revenue generating process.revenue. 

 

Other Income (Expenses)

 

Other income (expenses) for the three months ended September 30, 2018March 31, 2019 was $(4,664,704),$(179,447) as compared to $(2,014,823)$(770,053) for the three months ended September 30, 2017.March 31, 2018. Other expenses during the three months ended September 30, 2018March 31, 2019 was comprised of interest expense of $(279,163)$(54,569) on notes and related party notes, accretion of debt discount and issuance cost of $(1,449,656)$(47,364) due to the incentives given with debentures, and a loss on extinguishment of debt of $(2,938,719), and a gain on settlement of debt of $1,011 for the incentives given to amend or convert debt.$(77,514). During the three months ended September 30, 2017,March 31, 2018, other expenses were comprised of interest expense of $(228,120)$(268,125) on notes and related party notes and accretion of debt discount and issuance cost of $(800,614)$(174,888) due to the incentives given with debentures, gain on extinguishment of debtliabilities of $2,079$13,452 for the incentives given to amend or convert debt.

 

Net Loss

 

Net loss attributable to common shareholder for three months ended September 30, 2018,March 31, 2019, was $7,608,573,$1,884,441, or loss per share of $0.12,$0.01, as compared to a net loss of $3,495,979,$2,093,630, or loss per share of $0.09,$0.05, for the three months ended September 30, 2017.

Inflation did not have a material impact on the Company’s operations for the applicable period. Other than the foregoing, management knows of no trends, demands, or uncertainties that are reasonably likely to have a material impact on the Company’s results of operations.


Summary of Statements of Operations for the Nine Months Ended September 30, 2018 and 2017:

  Nine Months Ended 
  September 30,
2018
  September 30,
2017
 
Revenue $65,391  $105,345 
Operating expenses  (3,837,259)  (3,488,117)
Loss from operations  (3,771,868)  (3,382,772)
Other expenses  (6,280,292)  (2,995,102)
Net loss $(10,052,160) $(6,377,874)
Loss per common share – basic and diluted $(0.25) $(0.17)

Revenue

Revenue was $65,391 for the nine months ended September 30, 2018, as compared to $105,345 for the comparable nine months ended September 30, 2017, a decrease of $39,954. The decrease in revenue is primarily attributable to the Company’s transitioning from legacy businesses to generating revenue through native advertising, branded marketing, and affiliate sales, resulting from the creation of genre specific, user generated content community websites. As part of that transition, the Company focused its efforts throughout 2018 on the development of its proprietary Vocal software platform to support the scalability of its business model.

Operating Expenses

Operating expenses for the nine months ended September 30, 2018 were $3,837,259 as compared to $3,488,117 for the nine months ended September 30, 2017. The increase of $349,142 in operating expenses is the result of specific short-term expenses incurred in the first half of Fiscal Year 2018, including share-based payments, an increase in Jerrick's salesforce personnel, and elimination of accrued payables through June 2018, as well as a $719,151 increase in General and Administrative expenses related to the continued development of the Vocal platform and a $12,841 increase in compensation. These increased operating expenses were offset bya $382,850 decrease in consulting and professional fees due to the reorganization of management and related duties.

Loss from Operations

Loss from operations for the nine months ended September 30, 2018 was $3,771,868 as compared to loss of $3,382,772 for the nine months ended September 30, 2017. The increase in the loss from operations is primarily attributable to an increase in expenses related to the continued development of the Vocal platform and the launch of additional content, the decrease in sales and operating as a publicly traded company.

Other Income (Expenses)

Other income (expenses) for the nine months ended September 30, 2018 was $(6,280,292), as compared to $(2,995,102) for the nine months ended September 30, 2017. Other expenses during the nine months ended September 30, 2018 was comprised of interest expense of $(888,359) on notes and related party notes, accretion of debt discount and issuance cost of $(2,039,589) due to the incentives given with debentures, loss on extinguishment of debt of $(3,370,505), and a gain on settlement of debt of $2,886 for the incentives given to amend or convert debt. During the nine months ended September 30, 2017, other expenses were comprised of interest expense of $(372,825) on notes and related party notes and accretion of debt discount and issuance cost of $(1,525,514) due to the incentives given with debentures, loss on extinguishment of debt of $(923,822) for the incentives given to amend or convert debt.

Net Loss Attributable to Common Shareholders

Net loss attributable to common shareholder for nine months ended September 30, 2018, was $12,243,026, or loss per share of $0.25, as compared to a net loss attributable to common shareholders of $6,581,239, or loss per share of $0.17, for the nine months ended September 30, 2017. From the 2017 to 2018 periods, in addition to items explained above, the Company experienced a slight decrease in deemed dividends and a $2 million increase related to the issuance of additional securities as inducement to convert convertible preferred stock.March 31, 2018.

 

Inflation did not have a material impact on the Company’s operations for the applicable period. Other than the foregoing, management knows of no trends, demands, or uncertainties that are reasonably likely to have a material impact on the Company’s results of operations.

 

39

Off-Balance Sheet Arrangements 

 

As of September 30, 2018,March 31, 2019, we have no off-balance sheet arrangements. 

 

Critical Accounting Policies

 

We believe that the followingOur significant accounting policies are described in Note 2 of the most criticalCondensed Consolidated Financial Statements. During the three months ending March 31, 2019, we were not required to aid you in fully understanding and evaluating this “Management’s Discussion and Analysis of Financial Condition and Results of Operation.”

Use of Estimates

We usemake any material estimates and assumptions in preparing financial statements. Those estimates and assumptionsthat affect the reported amounts and related disclosures of assets, and liabilities, the disclosure of contingent assets and liabilities, and the reported revenuesrevenue and expenses. Actual results could differ from those estimates.

Fair Value Measurements

However, if we complete an acquisition, we will be required to make estimates and assumptions typical of other companies. For example, we will be required to make critical accounting estimates related to valuation and accounting for business combinations. The fair value of a financial instrument is the amountestimates will require us to rely upon assumptions that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participantswere highly uncertain at the measurement date. Financial assetstime the accounting estimates are markedmade, and changes in them are reasonably likely to bid pricesoccur from period to period. Changes in estimates used in these and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories: 

Level 1 – Quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and

Level 3 – Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

The Company recognizes income and expenses based on the accrual method of accounting.

Income Taxes

The Company utilizes the liability method of accounting for income taxes. Under the liability method deferred tax assets and liabilities are determined based on the differences between financial reporting and the tax bases of the assets and liabilities and are measured using the enacted tax rates and laws that will be in effect, when the differences are expected to reverse. An allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized.

Derivative Liability

The Company evaluates its debt and equity issuances to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 815-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.


The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions.  

The Company utilizes an option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The Company records the change in the fair value of the derivative as other income or expense in the consolidated statements of operations.

Adoption of ASU 2017-11

As noted above, in connection with the securities purchase agreement and debt transactions during the year ended December 31, 2017, the Company issued warrants and convertible notes, to purchase common stock with an exercise price of $0.20 and a five-year term. Upon issuance of the warrants and convertible notes, the Company evaluated the note agreement to determine if the agreement contained any embedded components that would qualify the agreement as a derivative. The Company identified certain put features embedded in the warrants and convertible notes that potentiallyitems could result in a net cash settlement in the event of a fundamental transaction, requiring the Company to classify the warrants and convertible notes as a derivative liability. The Company changed its method of accounting for the convertible notes and warrants through the early adoption of ASU 2017-11 during the three months ended December 31, 2017 on a retrospective basis. Accordingly, the Company recorded the warrant derivative and conversion option derivative liabilities to additional paid in capital upon issuance.

Stock Based Compensation

All stock-based payments to employees, non-employee consultants, and to nonemployee directors for their services as directors, including any grants of restricted stock and stock options, are measured at fair value on the grant date and recognized in the statements of operations as compensation or other expense over the relevant service period. Stock-based payments to nonemployees are recognized as an expense over the period of performance. Such payments are measured at fair value at the earlier of the date a performance commitment is reached or the date performance is completed. In addition, for awards that vest immediately and are non-forfeitable the measurement date is the date the award is issued.

Recent Accounting Pronouncements

The Company does not expect that the adoption of recent accounting pronouncements will have a material impact on itsour financial statements.statements in the future. Our estimates will be based on our experience and our interpretation of economic, political, regulatory, and other factors that affect our business prospects. Actual results may differ significantly from our estimates.

 


Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We do not hold any derivative instruments and do not engage in any hedging activities.

 

Item 4. Controls and Procedures.

 

(a) Evaluation of Disclosure Controls and Procedures.

 

In connection with the preparation of this Quarterly Report on Form 10-Q for the quarter ended September 30, 2018, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(e) under the Exchange Act) are not effective to ensure that information required to be disclosed by us in report that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, as appropriate to allow timely decisions regarding required disclosure.

 

(b) Changes in Internal Control over Financial Reporting.

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 


PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect. 

 

Item 1A. Risk Factors.

 

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on May 17, 2018 except with respect to the risk factors in our registration statements as set forth on Form S-1 filed with the Securities and Exchange Commission on October 24, 2018, as to which all such risk factors of the registration statements are incorporated herein by reference thereto.April 1, 2019.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

There have been no unregistered sales of equityDuring the three months ended March 31, 2019, we issued securities that havewere not beenregistered under the Securities Act, and were not previously disclosed in a Current Report on Form 8-K filed withor Quarterly Report on Form 10-Q as listed below. All of the securities discussed in this Item 5(e) were issued in reliance on the exemption under Section 4(a)(2) of the Securities and Exchange Commission. Act.

The June 2018 Frommer Loan Agreement

On February 18, 2019 the Company executed upon an agreement that extended the maturity date of the June 2018 Frommer Agreement to March 7, 2019. As part of the extension agreement, the Company issued Frommer an additional 41,534 warrants to purchase common stock of the Company at an exercise price of $0.30.

The First July 2018 Schiller Loan Agreement

On February 18, 2019 the Company executed upon an agreement that extended the maturity date of the First July 2018 Schiller Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Schiller an additional 64,077 warrants to purchase common stock of the Company at an exercise price of $0.30.

The Second July 2018 Schiller Loan Agreement

On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the Second July 2018 Schiller Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Schiller an additional 103,600 warrants to purchase common stock of the Company at an exercise price of $0.30.

The First July 2018 Rosen Loan Agreements

On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the First July 2018 Rosen Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Rosen an additional 207,400 warrants to purchase common stock of the Company at an exercise price of $0.30.

The Second July 2018 Rosen Loan Agreements

On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the Second July 2018 Rosen Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Rosen an additional 41,440 warrants to purchase common stock of the Company at an exercise price of $0.30.

The December 2018 Rosen Loan Agreement

On February 18, 2019 the Company executed upon an agreement that further extended the maturity date of the December 2018 Rosen Loan Agreement to March 7, 2019. As part of the extension agreement, the Company issued Rosen an additional 703,889 warrants to purchase common stock of the Company at an exercise price of $0.30.

The March 2019 Gravitas Capital Loan Agreement

On April 12, 2019 the Company executed upon an agreement that further extended the maturity date of the March 2019 Gravitas Capital Loan Agreement to May 15, 2019. As part of the extension agreement, the Company issued Gravitas Capital an additional 10,000 warrants to purchase common stock of the Company at an exercise price of $0.30.

The Company issued 2,000,000 shares of Common Stock to individuals in consideration for consulting services.

  

Item 3. Defaults Upon Senior Securities.

 

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company. 

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

There is no other information required to be disclosed under this item which was not previously disclosed.


29

Item 6. Exhibits.

 

Exhibit No. Description
4.1 Form of Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s current reportCurrent Report on Form 8-K filed with the CommissionSEC on August 31, 2018)
4.2Form of Incentive Warrant (incorporated by reference to Exhibit 4.2 to the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)February 26, 2019)
   
10.1 Form of Securities Purchase Agreement (incorporated herein by reference to Exhibit 10.1 to the Company’s current reportCurrent Report on Form 8-K filed with the CommissionSEC on August 31, 2018)February 26, 2019)
   
10.2 Form of Registration Rights Agreement10% Convertible Promissory Note (incorporated herein by reference to Exhibit 10.2 to the Company’s current reportCurrent Report on Form 8-K filed with the CommissionSEC on August 31, 2018)February 26, 2019)
   
10.316.1 Form of Lock-Up AgreementLetter from Sadler, Gibb & Associates, LLC, dated January 7, 2019 (incorporated herein by reference to Exhibit 10.316.1 to the Company’s current reportCurrent Report on Form 8-K filed with the CommissionSEC on August 31, 2018)
10.4Form of Series A Preferred Stock Conversion Letter Agreement (incorporated by reference to Exhibit 10.4 to the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)
10.5Form of Series B Preferred Stock Conversion Letter Agreement (incorporated by reference to Exhibit 10.5 to the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)
10.6Form of Convertible Note Conversion Letter Agreement (incorporated by reference to Exhibit 10.6 to the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)
10.7Form of Promissory Note Conversion Letter Agreement (incorporated by reference to Exhibit 10.7 to the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)January 8, 2019)
   
31.1* Certification by the Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).
   
31.2* Certification by the Principal Financial Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).
   
32.1** Certification by the Principal Executive Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2** Certification by the Principal Financial Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS* XBRL Instance Document
101.SCH* XBRL Taxonomy Extension Schema Document
101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* XBRL Taxonomy Extension Label Linkbase Document
101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith

** Furnished herewith


SIGNATURES

 

Pursuant to the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 JERRICK MEDIA HOLDINGS, INC.
   
Date: November 19, 2018May 15, 2019By:/s/ Jeremy Frommer
 Name: Jeremy Frommer
 Title:Chief Executive Officer
  (Principal Executive Officer)
  (Principal Financial Officer)
  (Principal Accounting Officer)

31